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SUMMARY 
 
1 
0 Summary 
 
Eukaryotic cells are compartmentalized by lipid membranes to achieve the spatial 
separation of biological processes and signaling pathways. Controlled trafficking of 
proteins between these compartments as well as the recruitment of proteins to the 
membranes themselves are crucial for trouble-free function of the cell. 
Previous research has revealed several possibilities for interaction between proteins and 
membranes. For instance, anionic lipids attract positively charged protein domains by 
electrostatic force, so that phosphoinositides can specifically interact with certain 
protein domains. 
This work focuses on the guanine nucleotide exchange factor ARNO, a multidomain 
protein that activates small GTPases like Arf6 and therefore is directly involved in the 
vesicle trafficking machinery of the cell. 
In its autoinhibited form, ARNO is localized in the cytoplasm, whereas recruitment to 
the plasma membrane is a prerequisite for its activation of Arf. 
In this context, previous research has been centered on the interaction of the PH-domain 
and the PBR-domain of ARNO with artificial membrane systems. To expand these 
findings in a system that accounts for the enormous complexity of the inner leaflet of 
the cellular plasma membrane, in this study, membrane sheets were employed. 
Systematically, the role of the different ARNO domains in binding to these sheets was 
analyzed. 
It has been shown, that the different domains of ARNO aid to the interaction with the 
membrane in a cooperative manner. The PH-domain absolutely is required for 
association with the membrane, yet it is not sufficient for sequestration of ARNO in the 
membrane. Moreover, its interaction with the phosphoinositides can be altered 
drastically by the second messenger Ca2+. Also, binding studies of the other ARNO 
domains conclusively showed, that the PBR-domain, the Sec7-domain as well as the 
coiled-coil domain participate in plasma membrane binding. Moreover, dimerization of 
ARNO also improves its binding ability, most probably by an increase of the local 
avidity. 
The microscopic analyses showed, that membrane-bound ARNO proteins are organized 
in clusters which, partly, are associated closely with EGFR clusters 
Overexpression of ARNO in HeLa cells results in a tendency towards increased 
activation of the EGFR after stimulation with EGF. 
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Both findings hint at a possible functional connection between ARNO and EGFR 
trafficking and phosphorylation, respectively that might be regulated by the second 
messenger calcium. 
Upon activation, the EGFR can be translocated to the nucleus by retrograde endosomal 
trafficking. In regards of this specific trafficking event, no influence of ARNO 
overexpression or inhibition was found. 
INTRODUCTION 
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1 Introduction 
 
1.1 The cell and its compartments 
All biological cells are compartmentalized by membranes. This is a prerequisite for the 
separation of metabolic reactions and biochemical processes that might interfere with 
each other as well as for the reduction of signaling noise 1,2. The origin of these 
compartments is subject to many speculations. Some of them, like mitochondria and 
plastids, most probably resulted from (endo-)symbiotic fusion of different cellular 
organisms. Others might be of autogenous origin, that is the development from 
preexisting intracellular structures as postulated for example for peroxisomes. However, 
it must be noted that for most organelles exogenous as well as autogenous origins have 
been proposed 3. 
For instance, the spatial separation of transcriptional and translational processes is a trait 
found in eukaryotic cells. As the nuclear envelope, that is composed of two membranes, 
is basically continuous with the endoplasmic reticulum´s membrane, the nucleus most 
probably originated autogenously by coevolution of at least 27 cellular components 4. 
As a consequence of cellular compartmentalization, many proteins regulate cellular 
processes depending on their subcellular localization 5. 
 
 
1.2 Membrane trafficking 
As the different compartments of the cell are diverse in protein and lipid composition, a 
flow of cargo-loaded membranous vesicles is crucial for the transport of 
macromolecules and the maintenance of homeostasis 6,7. This complex and highly 
regulated stepwise process has been coined “membrane trafficking”. In its chain of 
events, the coat of the vesicle is assembled, the cargo molecules are recruited to the 
donor membrane by carrier proteins before the vesicle buds from the compartment and 
is transported along the cytoskeleton. Delivery of the cargo is accomplished by tethering 
the vesicle to the membrane of the compartment of destination first, then docking it to 
the membrane irreversibly and finally fusing the transport vesicle with the acceptor 
compartment resulting in the release of the cargo 8. Thus, proteins can be sorted to the 
different organelles, specific intracellular membranes or secreted into the extracellular 
space. 
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Since the vesicles bud from the organelle membranes, they are delineated by a lipid 
bilayer 9. Three evolutionarily related coat proteins (COPI, COPII and Clathrin) 
comprise the framework for these cargo-bearing vesicles. COPII directs its cargo from 
the ER to the Golgi apparatus while COPI is responsible for retrograde transport in the 
opposite direction and transfer of proteins between the different Golgi cisternae. 
Clathrin-coated pits (CCP) bud from the plasma membrane (PM) and the trans Golgi 
network (TGN) to fuse with endosomes and lysosomes 7. However, it has to be noted 
that under biotic stress and during development, alternative secretory pathways can be 
employed by the cell 10. 
An overview over this network is depicted in Figure 1. 
 
Figure 1: Targeted protein transport between different cellular organelles and the 
extracellular space. Loaded cargo vesicles bud from the membranes and are directed to 
their destination depending, among other factors, on the specific coat proteins (COPI, 
COPII and Clathrin) that are embedded. ER = endoplasmic reticulum, LE = late 
endosome, MVB = multivesicular body. Figure inspired by 11. 
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1.3 Small GTPases 
Members of the Ras sarcoma (Ras) superfamily of small GTP hydrolases (GTPases) 
have been identified as major regulators of membrane trafficking as they are involved in 
almost all steps of this process. This superfamily is divided into five branches: Ras, 
Ras-like-proteins in brain (Rab), Ras-like-nuclear (Ran) proteins, Ras homologous 
(Rho) and ADP ribosylation factor (Arf) GTPases 12. For membrane trafficking, mainly 
members of the Rab and Arf subfamilies are important. By recruitment of effector 
proteins, they control cargo selection, vesicle budding, the kinetic movement of the 
vesicles as well as participate to change the membrane identity 13. Structurally, the 
members of the Ras superfamily are highly conserved, consisting of five α-helices and 
six β-sheets 14. 
 
 
1.3.1 The GTPase cycle 
As small GTPases function as nucleotide-dependent switches, they cycle between a 
GDP-bound “inactive” and a GTP-bound “active” conformation. Completion of this 
cycle is dependent on accessory proteins: guanine nucleotide exchange factors (GEFs) 
that facilitate release of GDP from and binding of GTP to the GTPase and GTPase 
activating proteins (GAPs) which stimulate the hydrolysis of bound GTP. Therefore, 
GEFs are commonly referred to as GTPase activators while GAPs are thought of as 
GTPase deactivators. This regulatory circle is schematically depicted in Figure 2 15. 
 
Figure 2: The GTPase cycle. GTPases like Arf cycle alternate a GTP-bound and a 
GDP-bound form. Transition between the two states is mediated by Guanine nucleotide 
Exchange Factors (GEFs), like cytohesins, and GTPase Avtivating Proteins (GAPs). 
Adapted from 16 
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However, as already illustrated in Figure 2, the terms “active” and “inactive” GTPase 
are somewhat misleading as both nucleotide-bound conformations have been shown to 
interact with a plethora of effectors and thus regulate different signaling pathways in a 
spatio-temporal specific manner. For example, Koo et. al. were able to demonstrate that 
GDP-bound Arf6 binds to and therefore recruits Kalirin to the plasma membrane what 
subsequently enables the activation of Rac GTPases 17. 
 
 
1.3.2 Arf GTPases and their role in membrane trafficking 
There is evidence, that the ADP ribosylation factor (Arf) family of small GTPases is 
one of the decisive components in managing coat recruitment as well as curvature 
generation 18. Arf proteins participate in vesicle formation by interacting with lipid-
modifying enzymes and the direct recruitment of coat proteins 19,20. In mammalian cells, 
this family is comprised of six members, namely Arf1-6, which are classified into three 
groups. Arf1-3 amount to Class I, though it is of note that Arf2 is absent in humans. 
Class II consists of Arf4 and 5 while Class III only contains Arf6. Class I and II Arfs 
predominantly localize to intracellular membranes of the Golgi and connected 
compartments as well as endosomes. Arf6, however, localizes to the plasma membrane 
upon activation 21. 
Notably, for efficient activation of Arf GTPases the presence of membranes is required. 
Unlike other GTPases, Arfs have a myristoylated amphipathic N-terminus that is 
shielded by a helix in the GDP-bound form, leading to cytosolic localisation. However, 
probably an equilibrium of loosely membrane-associated protein exists. Displacement 
of the N-terminal helix by membranes leads to conformational rearrangements priming 
the GTPase for subsequent activation by GEFs 22. 
 
 
1.3.3 The Sec7 family of guanine nucleotide exchange factors 
Fifteen Arf GEFs are encoded in the human genome, a relatively substantial number of 
activating proteins in relation to the six existing Arf GTPases. This already hints at a 
delicate regulation and the importance of selective recruitment of the specific GEFs. 
These GEFs are, based on structure and domain organization similarities, organized in 
five families, namely (i) Golgi Brefeldin A-resistance factor 1/Brefeldin A-inhibited 
GEF (GBF/BIG), (ii) Arf nucleotide binding site opener (ARNO)/cytohesin, (iii) 
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exchange factor for Arf6 (EFA6), (iv) Brefeldin-resistant Arf GEF (BRAG) and (v) F-
box only protein 8 (FBX8) 19. They all share the highly conserved catalytically active 
Sec7-domain. Its structure was solved by X-ray diffraction 20 years ago and contains 
ten α-helices, numbered A-J, that form an irregular right-handed superhelical 
conformation resulting in cylinder with a length of 70 Å and a diameter of 20 Å at the 
N-terminus, increasing to 40 Å at its C-terminus. It is separated into two motifs by a 
solvent-exposed hydrophobic groove (Figure 3) 23. 
 
 
Figure 3: Crystal structure of the ARNO Sec7-domain. The light blue arrowhead 
signifies the position of the Glu156, which is crucial for the catalytic function 23. 
 
Binding of Arf proteins to the Sec7-domain reduces the affinity of Arf for GDP for 
sterical as well as electrostatic reasons. The Sec7-domain perturbs the binding site for 
Mg2+ that coordinates the GDP´s β-phosphate thus facilitating release of the nucleotide. 
In addition, within the complex, the side chain of Sec7 Glu 156 is in the very close 
proximity of 3 Å to the β-phosphate resulting in profound steric as well as electrostatic 
repulsion 23; 24. 
A class of small molecules, coined Secins, is known to inhibit cytohesins in vitro as 
well as in vivo by specifically binding to its Sec7-domain. For instance, the compound 
Secin H3 binds the Sec7-domain of EFA6 30-fold weaker than to the cytohesin Sec7-
domain 25.  
 
 
1.3.3.1 Cytohesins 
In the following, this work is focused on cytohesins as they are one of the most 
important groups of Arf regulators. Cytohesins belong to the so-called small, i.e. 
relatively low–molecular weight, Arf-GEFs.Their Sec7-domain is flanked N-terminally 
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by a coiled-coil-domain (CC) and C-terminally by a pleckstrin homology-domain (PH) 
to which a polybasic, positively charged region (PBR) is linked. A schematic 
illustration of the domain organization of cytohesin 2/ARNO is presented in Figure 4 a. 
In 2007, X-ray-crystallography revealed that a recombinantly expressed Sec7-PH 
fragment of Cytohesin 3 adopts an autoinhibited conformation. The C-terminal helix, 
together with the linker between Sec7- and PH-domain, acts as a pseudosubstrate by 
interaction with the α-G and α-H helices thus blocking the binding sites for Arf and the 
catalytically active glutamic finger. Since the structure of the Sec7- and PH-domain is 
highly conserved in the cytohesin family, this autoinhibitory mechanism is considered 
to be the same for ARNO. A ribbon representation of the crystal structure of 
autoinhibited cytohesin 3 is shown in Figure 4 c 26. 
 
Figure 4: The structure of cytohesins. a) Cytohesins are comprised of four major 
domains: A coiled-coil (CC) responsible for protein-protein-interactions, the catalytic 
Sec7-domain, the pleckstrin homology (PH) domain that interacts with lipids as well as 
proteins and a C-terminal polybasic region (PBR) known to interact with negatively 
charged lipids. Adapted from 27. b) A model for the recruitment of GEFs and the release 
of autoinhibition by activated Arf-proteins resulting in a positive feedback loop. 
Adapted from 27. c) Crystal structure based on the Sec7-PH fragment of cytohesin 3. 
Ins(1,3,4,5)P4 atoms are represented by yellow (carbon and phosphate) and red 
(oxygen) spheres. Adapted from 26. 
 
a) b)
) 
 a) 
c)
) 
 a) 
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Interestingly, relief of this autoinhibition seems to be coupled to the binding to a 
membrane. As already presented in Figure 4 a, the PH- and PBR-domains of cytohesin 
has been shown to interact with phosphorylated, inositol containing phospholipids 
(PIPs) or negatively charged lipids like phosphatidylserine, respectively 28. However, 
two different splice variants of cytohesins exist, resulting in PH-domains containing two 
or three glycines, respectively. This leads to differences in PIP binding affinity: While 
the affinity for PIP2 is about the same, the 2G variant exhibits a ca 30-fold higher 
affinity for PIP3, which does suggest a layer of regulation additional to random PH-PIP-
interaction 29. Indeed, several groups reported, that GEFs are recruited by GTP-bound 
Arf of Arf-like proteins (Arls) resulting in a positive feedback loop. In vitro as well as 
in transfected cells, it could be shown that the PH-domain of ARNO at the same time 
interacts with Arf-GTP and PIP which leads to conformational changes of the linker 
region and the C-terminal helix, relieving the autoinhibition and therefore enabling the 
activation of more GTPase molecules. Schematically, this signal amplification is 
depicted in Figure 4 b 30; 31; 27. 
In spite of binding to PIP as well as membrane-bound Arf6, the ARNO PH-domain 
alone is not sufficient to mediate a persistent membrane association but needs at least 
the supporting interaction between the PBR-domain and phosphatidylserine 28. 
Evidently, coordinated membrane recruitment of GEFs is crucial for controlled GTPase 
signaling. Nonetheless, in how far the other cytohesin domains participate in protein-
membrane-interactions remains to be elucidated, even though one study suggests that 
the N-terminal coiled-coil-domain might impair binding of ARNO to membranes 32. 
Clarification of the different ARNO domains´ contribution to membrane binding is one 
of the main objectives of this thesis. 
Modification of cytohesins by phosphorylation appears to regulate the interaction 
between the cytohesin´s polybasic region and the plasma membrane. The Casanova 
group showed that phosphorylation of Serine 392 (S392) in the PBR reduces the 
interaction strength between ARNO and membranes both in vitro and in vivo, most 
probably due to the annihilation of positive charges 33. 
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1.3.4 Non-canonical functions of small GEFs 
It is of note that, for some small GEFs, rather unexpected cellular functions independent 
from their ability to trigger nucleotide exchange have been described, also referred to as 
non-canonical functions. For example, poliovirus replication employs the Arf GEF 
GBF1 independently from its Sec7 activity 34. 
Furthermore, the Bowerman group found that the N-terminus of the GEF EFA6 limits 
microtubule growth independently from Arf6 in the cortex of Caenorhabditis elegans 
(C. elegans) 35. 
Cytohesin 2 has been proposed as an enhancer of EGFR signaling by direct interaction 
with the EGFR. It should be noted, that more recently this model has been challenged 
due to non-reproducibility of the in vitro binding mode of ARNO to EGFR 36; 37; 38,39. 
 
 
1.4 Membrane recruitment of PH-domains via PIPs 
Since the interaction between PIPs and the PH-domain of ARNO is known to be 
involved in the membrane recruitment of the protein, it is important to understand the 
role of PIPs in the plasma membrane. 
Though low in abundance, about 1% in the plasma membrane, phosphorylated, inositol 
containing phospholipids (PIPs) regulate a plethora of biological functions by their 
interaction with proteins 40. Among these are protein trafficking, membrane curvature, 
the regulation of ion channels, immune cell functions and chemotaxis. As depicted in 
Figure 5 a, even though the inositol moiety contains five hydroxyl groups that 
theoretically could be phosphorylated, in nature only those at position -3, -4 and -5 have 
been found to be modified by kinases such as the phosphoinositide-3-kinase (PI3K), 
resulting in a family of seven different PIPs 41. 
Selectivity of the involvement in such an impressive number of signaling pathways is 
controlled by spatial and temporal distribution of the different PIPs. For example, 
PI(4,5)P2 and PI(3,4,5)P3 are most abundant in the plasma membrane while PI(3)P is 
detected in early endosomes and PI(3,5)P2 can be found in early endosomes, late 
endosomes and lysosomes. This specific distribution of PIPs provides the means for 
recruiting PIP-binding proteins specifically to the respective subcellular localization 40. 
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Figure 5: The structure of phosphatidyl inositol and its interactions with proteins. a) 
Structure of phosphatidyl inositol. The hydroxyl residues that can be phosphorylated in 
mammalian cell are indicated in red. b) Illustration of the four major ways in which 
PIPs interact with proteins. 1: High affinity interaction between PIP and protein. 2: 
Coincidence interaction, here in combination with another protein-protein interaction. 
3: Electrostatic interaction between the protein and the anionic lipid head groups. 4: 
Allosteric conformational change of the protein upon binding to PIP. Adapted from 42. 
 
Generally, PIPs interact with proteins and thus modulate their function in the respective 
signaling pathways in four different ways (Figure 5 b). 
1) Some proteins, like the general receptor protein 1 (GRP1) bind with high affinity 
to specific PIPs, for example PI(4,5)P2 and are thus transiently relocalized to the 
plasma membrane upon activation of the phosphoinositide-3-kinase (PI3K) 43. 
2) In other cases, the affinity for PIPs is too low to be sufficient for stable 
membrane association of the protein. The term “coincidence-detection” was 
coined to describe a cooperative increase of avidity by the PIP-protein-binding 
in addition to other molecular interactions. For example, sorting nexins employ 
the interaction of its PX-domain with PIPs in combination with membrane-
curvature-sensing by BAR domains to direct cargos differentially in the 
endosomal pathway 44. 
3) More trivially, some proteins, like K-Ras, interact with the plasma membrane by 
simple electrostatic interaction between the anionic lipid head groups with 
cationic, polybasic protein domains 45. 
4) Finally, in addition to simple membrane recruitment, for some proteins, e.g. the 
Arf GEF Brag2, the interaction with PIPs leads to an allosteric activation and 
therefore plays a direct role in modulation of signaling pathways 46. 
Since 2005, McLaughlin and colleagues suggested that eukaryotic cells use the 
regulation of its intracellular Ca2+ concentrations to control the level of accessible PIP2 
47.  
b)
) 
 a) 
a)
) 
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The ability to recruit proteins could consequently lead to protein clustering. For 
example, several proteins, such as for example Syntaxin 1A and myristoylated alanine-
rich C-kinase substrate (MARCKS), have been shown to be clustered along with PIP2 
thus forming microdomains in the plasma membrane 48. 
 
 
1.5 The role of PIPs in protein clustering 
Advanced microscopy has revealed that membrane proteins are not evenly distributed 
but organized in islands of high protein density 49. These protein islands are segregated 
by the cytoskeletal proteins actin and spectrin and depend on cholesterin 50. This 
demonstrates, that membrane protein distribution is governed by protein-protein as well 
as protein-lipid interactions. 
Within these protein rich regions in the plasma membrane, the proteins form nanoscale 
domains or clusters with a typical size of around 100 nm. Formation of these clusters is 
driven by forces which depend on the individual protein sequence, like the van der 
Waals force, electrostatic interactions and hydrogen bonding, as well as on membrane 
mediated interactions such as curvature or depletion mediated forces 51. 
On top of that, charged lipids like PIPs can themselves form microdomains, promote 
protein clustering and influence protein function. For example, PIP3 is required for 
maintenance of AMPA-type glutamate receptor (AMPARs) clusters in the postsynaptic 
membrane. Downregulation of PIP3 synthesis leads to increased mobility of AMPARs 
and synaptic dysfunction 52. 
Especially PIP2 plays a functional role in many protein clusters and microdomains, such 
as in Ca2+-dependent mesoscale domains with syntaxin 1a, a SNARE protein which is 
crucial for controlled exocytosis or the cell adhesion molecule CD44 clusters 53,54. 
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1.6 PIP2 in EGFR signaling 
The epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine 
kinase (RTK) superfamily and involved in transmembrane signaling resulting in cellular 
growth and replication. Hence, misregulation of the EGFR has been observed in many 
types of cancer 55. 
The 170 kDa glycoprotein is subdivided into a ligand-binding extracellular domain, a 
helical transmembrane domain, a positively charged, basic juxtamembrane domain, the 
catalytically active kinase core and a structurally flexible C-terminal tail 56. 
Activation of the EGFR requires binding of one of its seven peptide ligands, to its 
extracellular domain inducing conformational changes of the whole receptor which 
leads to formation of asymmetric homodimers with another EGFR molecule or 
heterodimers with other members of the family 57. In these dimers, the so-called donor 
kinase phosphorylates the receiver kinase initiating to receptor activation and 
phosphorylation of the C-terminal tail leading to downstream signaling (Figure 6) 58. 
 
 
Figure 6: EGFR activation. Binding of EGF induces a conformational change and 
receptor dimerization. The receiving kinase is then phosphorylated by the activating 
kinase leading to receptor activation. Figure inspired by 58. 
 
Since the intracellular part of the EGFR is highly active in solution, some studies 
suggest that the JM-domain´s ability to interact with the membrane is crucial for the 
receptor´s autoinhibition in the absence of ligand. They hypothesize, that one of the 
conformational changes that is required for the asymmetric dimer formation is the 
general extraction of the juxtamembrane domain from the plasma membrane 47,59. 
On the other hand, other groups focused on the aspect that the JM-domain´s cationic 
residues´ sequestering of PIP2 is actually aiding the stabilization of the active dimer 60–
62.  
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However, despite the controversy with respect to the exact nature of these interactions, 
their existence and regulatory importance is generally accepted. 
 
 
1.7 The different subcellular fates of the EGFR 
Binding of ligand to the EGFR sets off a plethora of intricately balanced signaling 
cascades and cellular mechanisms. One of them is the accelerated internalization of 
stimulated EGFR molecules. 
Generally speaking, a protein´s destination is mainly controlled by signaling peptides 
within their sequence, so-called localization signals, that are recognized by cargo 
receptors so that they are packed into the appropriate vesicles 11. 
Hence, subsequent subcellular localization is governed by four major factors 63: 
 
1) Which kind of localization signal is present in the protein sequence and how many of 
them are there? 
2) How strong is each of the localization signals? 
3) What´s the concentration of the protein? 
4) What´s the concentration and activity of the localization signal receptors? 
 
Post-translational modification of proteins provides an additional layer of control and 
has the advantage that it often is reversible and faster than the control of the protein 
expression. 
A prominent example for a post-translational modification involved in subcellular 
protein trafficking is the phosphorylation of the cargo protein nearby or in its 
localization signal. This can influence the protein´s binding affinity for its cargo 
receptor and therefore alter its transport, e.g. into or out of the nucleus 64. 
Some of the factors participating in the internalization and the destination of the EGFRs 
depend on the type of extracellular ligand, its concentration and the duration of the 
stimulus 65. 
This is of special interest since downregulation and trafficking of the EGFR is, given its 
involvement in multiple types of cancer and other diseases, of clinical relevance. A 
schematic overview of the different subcellular trafficking pathways of the EGFR is 
presented in Figure 7. 
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Figure 7: Illustration of EGFR trafficking in human cells. After ligand activation or 
other stimuli like irradiation, the EGFR molecules are internalized into early 
endosomes (EE) in the cell. From these, the EGFR can either be recycled back to the 
plasma membrane, translocated to the mitochondria or undergo retrograde Golgi 
transport to the nucleus (NPC = nuclear pore complex). Maturation of the early 
endosomes to late endosomes and eventually lysosomes leads to degradation of the 
EGFR molecules. 
 
 
1.7.1 Degradation and Recycling of the EGFR 
At physiologically low concentrations of EGF, the majority of EGFR dimers are quickly 
internalized by clathrin mediated endocytosis (CME). Interestingly, the enrichment of 
PIP2 in the plasmamembrane adjacent to the receptor is essential for vesicle formation 
66. The clathrin coated pits (CCP) fuse with a tubovesicular compartment known as the 
early endosome. Its lumen has a mildly acidic pH so that neither the EGFR dimers nor 
the EGFR-EGF-complex dissociate substantially, thus maintaining kinase activity. 
Other ligands, as Tumor Growth Factor alpha (TGFα), however, do dissociate from the 
receptor under these conditions. 67. 
From these early endosomes, most of the EGFR molecules are recycled back to the 
plasma membrane directly. Others are processed into the lysosomal pathway for 
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degradation. In this fate decision, the ubiquitination pattern of the EGFR´s lysine 
residues plays a crucial role 68. Early endosomes containing ubiquitinated EGFR 
complexes that can interact with sorting proteins like Endosomal Sorting Complex 
Required for Transport (ESCRT) mature to multivesicular bodies. From these, a slower 
recycling to the plasma membrane can occur. More common, however, is the fusion 
with lysosomes and subsequent degradation 66,67. 
 
 
1.7.2 Nuclear EGFR 
Active transport of proteins into the nucleus is a well-known mechanism for the 
transcriptional activation of certain target genes. 
For example, the CREB-regulated transcriptional activator (CRTC1), has been shown to 
couple synaptic stimulation in neurons to transcriptional activation 69. In unstimulated 
cells, phosphorylated CRTC1 is bound to the 14-3-3 protein and therefore localized 
cytoplasmatically. Depolarization of the neuronal cell leads to an increase of the 
intracellular Ca2+ level and subsequent activation of the Calcineurin phosphatase 70. 
Consequently, CRTC1 is dephosphorylated, dissociates from the 14-3-3 protein and is 
translocated from the cytoplasm in spine and dendrites of the neuron to its nucleus. 
There, CRTC1 acts as a transcription factor influencing, among other things, dendrite 
morphology and contextual memory 71. 
More than 25 years ago, the presence of nuclear EGFR (nEGFR) in adrenocortical 
carcinomas has first been reported 72. Since then, accumulating data report the 
translocation of the EGFR to the nucleus after its endocytosis. There, it regulates the 
transcription of a plethora of oncogenes by interaction with different transcription 
factors. Apparently, Importin β interacts with the EGFR´s tripartite, basic nuclear 
localization signal (NLS) which is located in its juxtamembrane domain. Subsequently, 
COPI-mediates the retrograde transport through the Golgi to the ER 73. Next, the EGFR 
is shuttled through the nuclear pore complex (NPC) and is released into the nucleoplasm 
in a Sec61β-dependent way 74. 
Nuclear EGFR has been detected in a multitude of tumors and cell lines and is 
correlated with poor overall survival, tumor size as well as resistance to chemo- and 
radiotherapy 75. This is due to its interaction with transcriptional regulators resulting in 
the upregulation of protooncogenes such as Cyclin D1 or B-Myb 76,77. Other interaction 
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partners of the nEGFR include members of the DNA repair machinery like DNA-PK or 
PCNA 78,79. 
An overview of the proteins the nEGFR is interacting with in the nucleus and the 
regulated genes is shown in Table 1. 
 
Table 1:Interaction partners and biological consequences of nuclear EGFR 
Interaction partner Regulated Gene Effect Source 
 c-fos  80 
LMP1, TIF2 Cyclin D1 Proliferation ↑, Genetic instability ↑, 
Gefitinib resistance ↑ 
81 
76 
STAT3 iNOS Inflammation ↑, Tumor progression ↑, 
Metastasis ↑ 
82 
E2F1 B-Myb Proliferation ↑ 77 
STAT3 STAT1 Inflammation ↑ 83 
STAT5 Aurora A Chromosome instability ↑ 84 
c-Src, STAT3 c-myc  85 
 Prostaglandine-
endoperoxide 
synthase 2, 
COX 2 
 86 
 HIF1A Angiogenesis ↑ 87 
 TWIST1  88 
 BCRP Drug resistance ↑ 89 
 Ki-76 Inflammatory response ↑ 90 
RNA helicase A   91 
MUC1  Chromatin-bound EGFR ↑ 92 
PCNA  Cell proliferation ↑, DNA repair ↑ 79 
DNA-PK  Repair of DNA ds breaks ↑ 93 
94 
78 
P53, MDC1  Formation of DNA repair foci ↑ 95 
PRKDC  Repair of DNA ds breaks ↑ 96 
PNPase  Radioresistance ↑ 97 
PMLIV  Transcriptional activity of nEGFR ↓, 
Tumor progression ↓ 
98 
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The role of nEGFR in healthy cells and the delicate regulation thereof is not fully 
understood, yet. However, the Promyleocytic Leukemia Protein (PML) Isoform IV 
decreases the transcriptional activity by direct interaction with and inhibition of the 
nEGFR 98. In how far nEGFR might play a role e.g. in protecting the cells from damage 
by natural UV-irradiation remains speculative and is subject to future investigation. 
INTRODUCTION 
19 
2 Aims of this study 
 
The purpose of this work is to gain a deeper understanding of the way the guanine 
nucleotide exchange factor cytohesin 2/ARNO interacts with plasma membrane 
components. Specifically, two main emphases are elucidated: 
 
1) ARNO is an activator of Arf GTPases and therefore involved in the intricately 
regulated vesicle trafficking machinery. In its inactive form, it is located in the 
cytoplasm, while activation of Arf requires binding of ARNO to the plasma 
membrane. Therefore, understanding the interaction between ARNO and the 
plasma membrane is important for comprehension of how intracellular vesicle 
trafficking is orchestrated. In this study, the question which domains of ARNO 
contribute to plasma membrane binding and how this binding can be modulated 
is addressed. 
 
 
2) During the last years, a functional relationship between ARNO and the EGFR 
has been discussed controversially. Since dysregulation of the EGFR is a trait 
found in many diseases such as cancer, unraveling every aspect of its function in 
detail is highly relevant for possible therapeutic approaches. This work examines 
the spatial relationship between ARNO and EGFR clusters in the plasma 
membrane, the impact of the overexpression of ARNO on the activity of the 
EGFR and its influence on the nuclear translocation of the EGFR. 
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3 Materials and Methods 
 
3.1 Materials 
 
3.1.1 Equipment 
 
Table 2: List of Equipment 
Equipment Manufacturer 
Analytical Balance Sartorius, BP 211D 
Blotting Chamber, wet BioRad 
Centrifuges Beckmann; Eppendorf 
Electrophoresis apparatus BioRad 
FPLC, ÄKTA Prima GE Healthcare Life Science 
French Press FA-032 Thermo Scientific 
Heating block Bachofer 
Incubator (bacteria) Innova 4430 Eppendorf 
Incubator (mammalian cells) Binder 
Infinite M1000 Pro plate reader Tecan 
Microwave Bosch 
Nanoquant Infinite M200 Tecan 
Odyssey Imager Li-COR 
Overhead-tumbler Grant-Bio 
Peristaltic pump Mettler Toledo 
pH-Meter Mettler Toledo 
Pipette-boy Brand GmbH & Co 
Pipettes Eppendorf 
Protino Ni-NTA columns 5 ml Macherey Nagel 
Sterile Hood (mammalian cell culture) Heraeus 
Superdex 200 HR 10/30 column GE Healthcare Life Science 
Tecan M1000 Pro Infinite Tecan 
UV/Vis Spectrophotometer Thermo Spectronic 
Vortex Zx3 Velp Scientifica 
Water bath GFL 
Water purification system  TKA-Lab 
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Table 3: Fluorescence microscope IX81 (Olympus, Tokyo, Japan) 
Equipment Specifications Company 
Objective 60x 1,49 NA Apochromat oil 
immersion 
Olympus, Germany 
Lamp 150W Xenon Olympus, Germany 
Filter sets F36-500 DAPI HC 
F36-525 EGFP HC 
F46-009 Cy5 ET 
F36-503 TRITC HC 
AHF Analysentechnik AG, 
Tübingen, Germany 
Detector EMCCD camera 
ImagEM C9100-13  
Hamamutso Photonics, 
Japan 
Software Xcellence rt 1.2 Olympus, Germany 
 
Table 4: STED microscope easy-3D (Abberrior, Göttingen, Germany) 
Equipment Specifications Company 
Objective UPlanSApo 100x/NA 1.4 oil 
immersion 
Olympus, Hamburg, 
Germany 
Lamp Pulsed 488 nm excitation laser 
Pulsed 640 nm excitation laser 
Pulsed 775 nm STED laser 
Abberior Instruments 
Abberior Instruments 
MPBC, Montreal, Canada 
Filter sets 500-520 nm filter set 
650-720 nm filter set 
Abberrior Instruments 
Detector Single photon counting modules Excelitas, Waltham, MA 
Software Imspector version 0.10 & higher Abberior Instruments 
 
Table 5: Confocal microscope Eclipse Ti (Nikon, Düsseldorf, Germany) 
Equipment Specifications Company 
Objective CFI Plan Fluor 40X Oil, NA 1.3 
CFI Plan Apo Lambda 20X, NA 0.75 
Nikon 
Lamp Intensilight 
488 nm argon ion laser 
562 nm saphire laser 
640 nm two-diodes laser 
Nikon 
Melles Griot, Bensheim 
Coherent, Dieburg, 
Germany 
Melles Griot 
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Filter sets 525/50 
595/40 
Nikon 
Dichroic 
mirrors 
DAPI/Cy5 dual MHE 46660 Nikon 
Detector Four Photomultipliertubes Nikon 
Software NIS Elements C Nikon 
 
Table 6: Automated confocal microscope system Cell Voyager CV6000 (Yokogawa 
Inc., Ratingen, Germany) 
Equipment Specifications Company 
Objective 20x water immersion 
40x water immersion 
Olympus, Germany 
Lamp 488 nm excitation laser 
561 nm excitation laser 
Coherent 
Filter sets BP 522/35 
BP 600/37 
Semrock 
Detector Four EMCCD cameras Hamamatsu Photonics 
Software CV 6000 Analysis Software Yokogawa 
 
 
3.1.2 Consumables 
 
Table 7: List of consumables  
Consumable Manufacturer 
Blotting papers Macherey Nagel 
Cell culture dishes, Ø 6 cm, 10 cm TPP 
Cell culture flasks, 75 cm2 TPP 
Cell culture plates, 6-well TPP 
Centricon centrifugal filter (30 kDa cutoff) Millipore 
Centrifugation tubes (15ml and 50ml) Falcons or TPP 
Clear 96 – well – plate  Greiner 
Coverslips for confocal microscopy, Ø 13 mm, No. 1 VWR 
Coverslips for epifluorescence microscopy, Ø 25 mm, 
No. 1 
Marienfeld 
Coverslips for STED microscopy, 22x22 mm, No. 1.5 Marienfeld 
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(high precision) 
Disposable cuvettes, 1 ml Roth 
Hamilton Syringes Sigma-Aldrich 
Membrane filter paper, thickness 1 mm Sigma-Aldrich 
Microscope slides, 75x25 mm VWR 
Ni-NTA agarose, bead size 45-165 nm Qiagen 
Nitrocellulose paper Whatmann 
Parafilm Roth 
Petri dishes, Ø 6 cm, 10 cm Faust 
Pipette tips, 0.1-10 µl, 2-200 µl, 50-1000 µl Eppendorf and Peske 
Reaction tubes, 1.5 ml and 2 ml Eppendorf or Sarstedt 
Serological pipettes (2 ml, 5 ml, 10 ml, 25 ml, 50 ml) Sarstedt 
Streptactin High Capacity beads, cat#: 2-1208-010 Iba 
Subcellular Protein Fractionation Kit Thermo Fisher 
Syringes Braun 
TetraSpeck beads, 100 nm Thermo Scientific 
Vivaspin Turbo15 concentration falcons Sartorius 
 
 
3.1.3 Chemicals and Reagents 
 
Table 8: List of Chemicals and (bio-)reagents  
Substance Manufacturer 
Acetic acid Roth 
Acetone Roth 
Acrylamide – Bisacrylamide solution (37.5 : 1) Roth 
Agar Roth 
Ampicillin, cat#:69-53-4 Sigma-Aldrich 
Ammoniumperoxidesulphate (APS) Roth 
β-Mercaptoethanol Roth 
Bradford Assay Reagent, cat#: 5000006 BioRad 
Bromophenol blue Merck 
BSA Sigma-Aldrich 
Chloramphenicol Sigma-Aldrich 
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Coomassie Brilliant Blue R250 Biorad 
Dimethylsulphoxide (DMSO) Fluka 
Dithiotreitol Roth 
DraQ5, nuclear dye Thermo Fisher 
EGF, cat#: CYT-217 Peprotech 
Ethylendiaminetetraacetic acid (EDTA) AppliChem 
Ethanol Roth 
G-418 Sulfate / Geneticin, 20ml, cat# 10131027 Thermo Fisher 
Glutamine PAN 
Glycine Roth 
HEPES Roth 
Hydrochloric acid VWR Chemical 
Imidazole Roth 
Isopropanol Roth 
Isopropyl β-1-thiogalactopyranoside (IPTG) Carbolution Chemicals 
Kanamycin, cat# T832.4 Roth 
Lipofectamine LTX PLUS Thermo Fisher 
Magnesium chloride Acros organics 
Methanol Roth 
Mounting Solution Aqua Polymount Polysciences Inc. 
N,N,N´,N´- Tetramethylendiamine (TEMED) Merck 
PAGE Ruler Prestained Plus Thermo Scientific 
Penicillin/Streptomycin PAN 
ProLong Gold Antifade Mountant Thermo Fisher 
Protease Inhibitor Cocktail Roche 
Protein Assay Dye Reagent Concentrate (5x) BioRad 
Sodium bicarbonate Merck 
Sodium chloride Roth 
Sodium cholate Sigma-Aldrich 
Sodium dodecyl sulphate (SDS) Roth 
Sodium orthovanadate AppliChem 
Thimerosal AppliChem 
TMA-DPH, cat#: T204 Thermo Scientific 
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Trifluoracetic acid Roth 
Tris Roth 
Triton X-100 AppliChem 
Tween 20 AppliChem 
Urea Roth 
 
 
3.1.4 Buffers and Solutions 
 
Table 9: Buffer compositions and solutions 
Buffer Composition 
Protein purification  
Lysis / Washing buffer I 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
20 mM Imidazole 
10 % v/v Glycerol 
Elution buffer SBP-Tag Lysis / Washing buffer I 
+ 2.5 mM Desthiobiotin 
Elution buffer His-Tag Lysis / Washing buffer I 
+ 250 mM Imidazole 
TEV digest buffer 50 mM Tris-HCl pH 7.8 at 4 °C 
300 mM NaCl 
TEV wash buffer TEV digest buffer 
+ 20 mM Imidazole 
HEPES buffer for storage  20 mM HEPES 
150 mM NaCl 
SDS-PAGE   
4x Stacking gel buffer 500 mM Tris-HCl, pH 6.8 
13.87 mM SDS 
4x Separating gel buffer 1.5 M Tris-HCl, pH 8.8 
13.87 mM SDS 
6x Sample buffer 50 mM Tris-HCl, pH 6.8 
30 % Glycerol 
15 % w/v SDS 
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600 mM DTT 
1 mg Bromophenol blue 
Coomassie staining  
Staining solution 30 % v/v methanol 
10 % v/v acetic acid 
700 mg/l Coomassie Brilliant Blue R250 
Destaining solution 30 % v/v methanol 
10 % v/v acetic acid 
Western Blot  
1x Lysis Buffer II 20 mM Tris-HCl, pH 7.5 
150 mM NaCl 
1 mM EDTA 
1 mM EGTA 
2.5 mM sodium pyrophosphate 
1 mM β-glycerophosphate 
1 mM sodium vanadate 
1 % (v/v) Triton-X 100 
10x Wetblot buffer 250 mM Tris 
1.92 M Glycine 
Blocking buffer (5% BSA in TBST) 20 mM Tris-HCl pH 7.4 
136 mM NaCl 
Tween 20 0.1 % v/v 
BSA 5 % w/v 
10x PBS 1.37 M NaCl 
27 mM KCl 
80 mM Na2HPO4 
20 mM KH2PO4 
4x Sonication buffer 80 mM HEPES-KOH, pH 7.2 
480 mM potassium glutamate 
80 mM potassium acetate 
40 mM EGTA 
Quenching buffer 50 mM NH4Cl in PBS 
LB medium 20 g LB broth / 1 l ddH20 
LB agar solution LB medium supplemented with 15 g/l agar 
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PLL Stock solution 2 mg/ml in ddH2O 
 
 
3.1.5 Biological materials 
 
3.1.5.1 Antibodies 
 
Table 10: List of antibodies  
Antigen Catalog # Host 
species 
Fluorophore Dilution Manufacturer 
EGFR  SC-03 Rabbit - 1:50 – 1:100 
IF 
Santa Cruz 
EGFR CS4267 Rabbit - 1:1000 WB 
1:50 IF 
Cell Signaling 
EGFR PA1-1110 Rabbit - 1:100 Abcam 
EGFR 
pY1086 
Ab32086 Rabbit - 1:1000 Abnova 
SBP-Tag SC101595 Mouse - 1:50 Santa Cruz 
ARNO Ab56510 Mouse - 1:500  Abnova 
Lamin SC-7292 Mouse - 1:1000-2000 Santa Cruz 
GAPDH SC-25778 Rabbit  1:1000  Santa Cruz 
Rabbit IgG A-21206 Donkey Alexa 488 1:200 Thermo Fisher 
Mouse IgG  A-21203 Donkey Alexa 594 1:200 Thermo Fisher 
Rabbit IgG Ab150064 Donkey Alexa 594 
(STED) 
1:200 Abcam 
Mouse IgG 50185 Goat Atto 647N 
(STED) 
1:200 Sigma 
Mouse IgG CS5257 Goat DyLight800 1:15000 Cell Signaling 
Rabbit IgG 926-32213 Donkey IR800CW 1:20000 LiCOR 
 
 
3.1.5.2 Organisms 
 
Table 11: List of Organisms 
Organism Source 
E.coli BL21DE3 Famulok group (V. Fieberg) 
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E.coli XL10-Gold Agilent technologies 
HeLa (human cervix cancer cell) – adherent, cat#: CCL-
2 
ATCC 
MDA-MB-468 (human mammary gland / breast cancer 
cell), cat#: HTB-132 
ATCC 
 
 
3.1.5.3 Plasmids 
 
Table 12: List of Plasmids for protein expression* 
Construct Temperature Induction time Antibiotic 
pET28ST-ARNO-PH clone 20 20 °C Over night Kanamycin 
pET28ST-ARNO-Sec7 37 °C 4 h Kanamycin 
pET28ST-ARNO 20 °C Over night Kanamycin 
pET28ST-ARNO E156K 20 °C Over night Kanamycin 
pET28ST-ARNO R280C 20 °C Over night Kanamycin 
pET28HT-ARNO-mEGFP 20 °C Over night Ampicillin 
pET28HT-ARNO-PH-mEGFP 20 °C Over night Ampicillin 
pET28HT-ARNO-Sec7-PH-mEGFP 20 °C Over night Ampicillin 
pET28HT-ARNO-deltaCC-mEGFP 20 °C Over night Ampicillin 
pET28HT-Gen4Lz-Sec7-PH-mEGFP 20 °C Over night Ampicillin 
pET2828HT-ARNO-∆PBR-mEGFP 20 °C Over night Ampicillin 
*all plasmids were a kind gift from Dr. Anton Schmitz (AG Famulok) 
 
Table 13: List of Plasmids for mammalian expression* 
Construct Antibiotic resistance 
pGFP-PK Zeocin 
pGFP-EGFRJM-PK Zeocin 
pCMVTag2-ARNO - 
pCMVTag2 - 
*all plasmids were a kind gift from Dr. Anton Schmitz (AG Famulok) 
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3.1.5.4 Culture medium 
 
Table 14: Culture media 
Medium Manufacturer 
DMEM PAN 
Fetal Calf Serum (FCS) Biochrom 
LB Medium Roth 
MEM PAN 
RPMI PAN 
1x PBS PAN 
Trypsin/EDTA (10x) PAN 
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3.2 Methods 
If not specified otherwise, experiments were performed at room temperature. All 
experiments involving living mammalian cells were carried out under sterile conditions. 
 
 
3.2.1 Protein methods 
 
3.2.1.1 Transformation of plasmid DNA into E. coli 
An aliquot of competent E. coli strain BL21DE3 was thawed on ice. 500 ng of plasmid 
were added to 45 µl of bacteria and incubated on ice for 30 min followed by a heatshock 
of 42 °C for 45 sec. Subsequently, the mixture was put on ice immediately and cooled 
down for 10 min. Addition of 300 µl LB medium was followed by incubation in a 
thermoblock at 37 °C shaking at 800 rpm for 1 h to allow for the development of the 
antibiotic resistance. Then the mixture was plated on an agar plate containing 50 µg/ml 
kanamycin or 100 µg/ml ampicillin which was then incubated at 37 °C overnight. 
 
 
3.2.1.2 Expression of proteins 
200 ml of LB medium containing 50 µg/ml of the appropriate antibiotic were inoculated 
with a pipette tip which had been dipped into a colony on the agar plate and incubated 
overnight at 37 °C, shaking. Next, this preculture was added to 2 l LB medium 
containing 5 µg/ml antibiotic and grown until the optical density at 800 nm was 0.2. 
Protein expression was induced by addition of 0.5 mM IPTG. For temperature and 
induction time see Table 12. Bacteria were harvested by centrifugation for 20 min at 
4000 rcf and a temperature of 4 °C in the JA25.5 rotor. The pellets were either directly 
subjected to protein purification or stored at -80 °C. 
 
 
3.2.1.3 Purification of Streptavidin-binding-peptide (SBP)-tagged proteins 
The streptavidin-binding-peptide is composed of 38 amino acids and binds to the 
tetrameric protein streptavidin with an affinity of 2.5 – 4.9 nM. This interaction can 
therefore be employed for protein purification 99. To protect the protein of interest from 
degradation, all purification steps were performed with precooled buffers at 4 °C. 
MATERIALS & METHODS 
31 
The E.coli pellet obtained from 2 l of culture was thoroughly resuspended in 10 ml 
Lysis buffer. 4 ml of a 50 % Streptactin High Capacity beads solution was equilibrated 
in Lysis buffer and centrifuged at 4 °C and 1900 rcf for 10 min. 
The bacterial cell membranes were disrupted by passing them twice through a French 
press with a pressure between 1200 and 1500 bar. Next, the lysate was separated from 
the cell debris by centrifugation for 30 min at 20000 rcf at 4 °C (rotor JA 25.5). Pellets 
were discarded and the supernatatant was incubated with the equilibrated affinity beads 
in a 15 ml falcon for 1 h in the overhead tumbler to allow the SBP-tag to bind to the 
Streptactin beads. Afterwards, the beads were centrifuged for 5 min at 1900 rcf at 4 °C 
and, after discarding the supernatant, resuspended in 12 ml pre-cooled lysis buffer. This 
washing step was repeated three times before the beads were loaded onto a disposable 
column and a peristaltic pump was employed for three more wash steps with lysis 
buffer. 
Elution of the protein of interest was achieved by three subsequent incubations of the 
beads with elution buffer for 5 min. 
 
 
3.2.1.4 Size exclusion chromatography (SEC) with FPLC 
All eluates, except for those of the SBP-PH-construct, were concentrated to 3 – 5 ml 
using a Vivaspin concentrator falcon with the appropriate molecular cutoff. Then, the 
eluates were loaded onto a HiLoadTM 16/600 Superdex 200 pg SEC column which had 
previously been equilibrated with HEPES buffer for storage. The flow of the Ekta Pure 
FPLC was set to 1 ml/min. Peak fractions were collected, concentrated with a Vivaspin 
concentrator and the concentration was determined. Typically, the volume was about 2 
ml with a concentration of 50-100 µM. The protein was then aliquoted, flash frozen in 
liquid nitrogen and stored at -80 °C. 
 
 
3.2.1.5 Purification of hexa–histidine-tagged proteins 
The basic protein purification steps are the same as described in chapters 3.2.1.1 - 
3.2.1.4, except for the use of 3 ml Protino Ni-NTA Agarose affinity beads slurry per 1 l 
of E. coli culture and the Lysis buffer I + 250 mM imidazole for elution. 
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3.2.1.6 Tobacco etch virus digest 
In case of the GFP-constructs, the His-tag was fused to the protein chain by a linker 
containing a recognition site for the tobacco etch virus (TEV) protease allowing for 
cleavage to separate the tag from the protein.  
The eluate was centrifugated for 15 min at 4 °C at 14000 rcf and the supernatant was 
injected into the Ekta Pure FPLC to change the buffer and get rid of the imidazole 
before the TEV digest. Peak fractions were collected and pooled. Per ml eluate, 1 µl of 
0.5 M EDTA and 2 µl β–mercaptoethanol and one aliquot of TEV protease, which was 
homemade in the AG Famulok, were added. 
The samples were incubated over night in the overhead tumbler @4 °C. 
To remove the cleaved tag, 3 ml of Ni-NTA Agarose affinity beads slurry were 
equilibrated with TEV digest buffer. The solution was added and incubated for 30 – 60 
min at 4 °C in the overhead tumbler. The mixture was then added to a disposable 
column and subjected to gravity flow. The protein of interest was in the flowthrough, 
while the cleaved his-tags as well as uncleaved constructs remained bound to the beads. 
One wash step was performed with 3 ml washing buffer and the wash flowthrough was 
combined with the initial flowthrough. 
Subsequently, the protein solution was concentrated using Centricon centrifugal filters 
with the appropriate cutoff and the concentration was determined using the nanodrop. 
Typically, the volume was about 2 ml with a concentration of 50-100 µM. 
 
 
3.2.1.7 SDS-PAGE 
SDS-polyacrylamide-gel-electrophoresis (SDS-PAGE) is the separation of proteins 
based on their molecular weight by application of an electric field to a gel. The anionic 
detergent SDS binds to proteins in a ratio of 1.4 g SDS per 1 g protein thus dominating 
the protein´s overall charge. Therefore, separation of the proteins is charge independent 
from their isoelectric point 100. 
Samples were diluted in 6x sample buffer and boiled for 5 min before loading them onto 
a gel with the appropriate acrylamide percentage. 
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Table 15: Pipetting scheme for SDS PAGE gels 
Component Composition Separating gel [µl] Composition 
Stacking gel [µl] 
 8 % 10 % 12.5 % 15 % 4 % 
Acrylamide 1333 1667 2083 2500 213 
Water  2379 2045 1629 1212 975 
Separating gel 
buffer 
1250 - 
Stacking gel 
buffer 
- 400 
TEMED 8 2 
APS 30 10.4 
Total 5000 5000 5000 5000 1600.4 
 
On each gel 5 µl of the PAGE Ruler Prestained Plus were loaded as a standard ladder 
indicating the running height of proteins. 
Gels were run at 170 V for 50 – 60 min in 1x running buffer using a BioRad 
electrophoresis apparatus. 
For protein visualization, the gels were incubated in Coomassie staining solution (see 
Table 9) for at least 30 min, gently shaking. The staining solution was recovered, and 
the gel rinsed once with destaining solution. Next, the gels were generously covered 
with destaining solution, shortly heated in the microwave and shaken for about 20 min. 
The gels were imaged using the Odyssey Imager. 
Destaining solutions were recycled by passing them through a funnel that had been 
lined with filter paper and filled with active charcoil. 
 
 
3.2.1.8 Westernblot 
Proteins can be transferred from SDS-PAGE gels to nitrocellulose membranes by use of 
an electromagnetic field. Two sponges, two pieces of Whatman paper, one 
nitrocellulose membrane and the SDS-PAGE gel were equilibrated in Wetblot buffer. 
The blot was assembled as depicted in Figure 8 within the buffer in the equilibration 
basin. 
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Figure 8: Building scheme of a wet westernblot system. All components of the wetblot 
had been equilibrated in wetblot buffer at 4 °Cprior to construction. 
 
Then, the blot was placed into the wetblot chamber together with a coolpack and an 
electromagnetic field of 100V and 2 Ampere (A) was applied for 1 hour while the 
buffer was stirred by a magnetic stirrer. 
Afterwards, unspecific binding of antibodies to the nitrocellulose membrane was 
blocked with 5 % BSA in TBST except for the ARNO blots that were blocked with 5 % 
milk powder in TBST. If necessary, the westernblots were cut according to the 
molecular weight standard and incubated separately with primary antibodies diluted in 5 
% BSA in TBST at dilutions as stated in Table 10 overnight at 4 °C, shaking gently. 
The primary antibodies were recovered and stored at 4 °C to be reused twice at 
maximal. The blots were washed three times for five minutes with TBST and then 
incubated with the secondary antibody diluted in 5 % BSA in TBST at dilutions as 
stated in Table 10 for 1 hour at room temperature. 
Having recovered the secondary antibodies, the blots were washed three times for five 
minutes with TBST and imaged using the Odyssee reader. Quantification of the bands 
was done with the Image Studio Lite Ver. 3.1. 
 
 
3.2.2 Cell Culture 
 
3.2.2.1 Cleaning and PLL-coating of coverslips 
For some experiments, cells were plated onto glass-coverslips. Prior to using them for 
cell culture and microscopy, residual oil and other soiling from the production process 
needed to be removed. 
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To this end, 500 coverslips were rinsed five times with dH2O in a 1 l beaker. Swirling of 
the coverslips was done manually to avoid mechanical damage. Afterwards, the 
coverslips were washed with 1 M HCl for 1–2 hrs swirling them every twenty minutes 
before being rinsed ten times with dH2O. Afterwards, the coverslips were rinsed three 
times with 100 % EtOH (p.a.) and then kept with 100 % EtOH (p.a) overnight. On the 
next day, the EtOH was removed and the coverslips sterilized in an oven at 180 °C. 
For subsequent sheeting experiments, it was necessary to enable the cells to adhere 
firmly to the coverslips. In order to achieve this, the coverslips were coated with poly–
L–Lysine (PLL). 
First, the PLL–stock solution at a concentration of 2 mg/ml was filtered and diluted 20-
fold in ddH2O. One coverslip in a well of a cell culture 6–well plate was covered with 
500 µl of the PLL–solution, which forms a meniscus due to the water´s surface tension, 
and incubated for 30 min. Subsequently, the PLL-solution was removed and the 
coverslips were dried for at least 1 h before they were sterilized by irradiation with UV 
light for 20 min. Coated coverslips were stored within the 6-well-plates at 4 °C. 
 
 
3.2.2.2 Passaging and counting of HeLa and MDA-MB-468 cells 
Growth medium was removed from the cells and the flask was rinsed with 10 ml of 
PBS to remove residual medium. Per 75 cm2 cell culture flask, 2 ml of Trypsin/EDTA 
reagent was added and it was ensured that the complete surface was covered. After 
incubation for 5 min at 37 °C, 8 ml of growth medium was added and pipetted up and 
down several times to detach all cells. Approximately 9.8 ml cell suspension was then 
taken out of the flask and 25 ml growth medium was added. 
Ten µl of the cell suspension was diluted 10-fold in PBS and the cells were counted in a 
Neubauer chamber. Cell concentration could then be calculated by the formula 
 
C = N / S * 105 
 
Where C is the concentration of cells in #/ml, N is the cell count of the 10-fold dilution 
and S signifies the number of squares that had been used for counting in the Neubauer 
chamber. Usually, all eight squares were counted. 
Consequently, appropriate numbers of cells could then be plated for subsequent 
experiments. 
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3.2.2.3 Preparation of stable HeLa cell lines 
First, the plasmids were transfected into HeLa cells that had been seeded into 6-well-
plates at a density of 3.75 x 105 cells/dish the day before. 
 
Table 16: Transfection of HeLa cells with Lipofectamine LT1 kit 
Component Amount 
DMEM 250 µl 
Plasmid DNA 2.5 µg 
LT1 12.5 µl 
 
The transfection mixture was incubated for 25 min at room temperature before being 
added to the cells. 48 hours later, the transfected cells were transferred to a 15 cm2 cell 
culture dish. For selection of successfully transfected cells, the antibiotic G-418 was 
added leading to a final concentration of 800 µg/ml. The G-418-supplemented medium 
was renewed daily for ten days. Then, single colonies were picked by local trypsination 
of the colonies and transfer into 6-well-plates. After verification of the correct 
subcellular localization of the fluorescent constructs by microscopy, the cell populations 
were sorted by fluorescence activated cell sorting (FACS) to obtain monoclones. 
Subsequently, the cell lines derived from these monoclones were always cultured in 
DMEM containing 10 % FCS and 800 µg/ml G-418 to prevent loss of the construct. 
 
 
3.2.2.4 Membrane sheets 
To be able to access the inner leaflet of the plasma membrane of the cell, so-called 
membrane sheets were prepared from cells grown on glass-coverslips. 
About 1.5 * 105 cells were plated per coverslip and grown over night. One coverslip at a 
time were placed at the bottom of a petri dish completely filled with sonication buffer 
that had been precooled to 4 °C. The cells were facing up and 5 mm distant from the 
sonicator tip. A 0.1 s ultrasound pulse was applied to “unroof” the cells so that only the 
basal plasma membrane remained attached to the coverslip. The coverslip was taken out 
of the petri dish, briefly dried from excess sonication buffer by touching its rim with a 
soft paper towel and then subjected to protein incubation. 
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Unless specified otherwise, the membrane sheets were incubated with a 1 µM protein 
solution in sonication buffer face down on parafilm for 5 min at room temperature. 
 
3.2.3 Experiments with HeLa cells  
 
3.2.3.1 Transfection 
DNA delivery into eukaryotic cells can be facilitated by formation of complexes 
between the plasmid DNA and cationic lipids used as transfection reagents. These 
complexes form micelles that then interact with the cells and trigger endocytosis. 
One day before transfection, 0.75-1 * 106 cells were plated per 6-cm-dish. 
The mixtures of plasmid and transfection reagent were prepared as indicated in Table 
17. 
 
Table 17: Scheme for transfection of mammalian cells using the Lipofectamine LTX PLUS 
kit 
Component Mixture A Mixture B 
RPMI 225 µl 225 µl 
Lipofectamine LTX 13.5 µl  
Mock plasmid - 3.75 – x µg 
Plasmid of interest - x µg 
PLUS Reagent - 3.75 µl 
 
Mixture B was added to mixture A and incubated for 5 min. Then, the mixture was 
added dropwise to the culture medium of the cells for incubation overnight. 
 
 
3.2.3.2 Stimulation and lysis 
One day before stimulation, the culture medium, still containing transfection reagent, 
was exchanged for starving medium that is medium not supplemented with FCS. The 
objective for this is to be able to perform the experiment with completely unstimulated 
EGFRs which then can be stimulated in a precisely defined way as opposed to working 
with an equilibrium of stimulated and unstimulated EGFRs in FCS-containing medium. 
For stimulation, the starving medium was replaced by medium supplemented with 50 
ng/ml EGF for 5 min. Cells were kept on ice and scraped off in ice in 2 ml ice-cold 
PBS. The cells in the suspension were harvested by centrifugation for 8 min at 800 rcf 
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at 4 °C. Then, the cell pellet was resuspended in 50-100 µl Lysis buffer supplemented 
with proteinase inhibitor at a 1:100 dilution. The mixture was incubated on ice for 20 
min and thoroughly vortexed every 5 min. Afterwards, it was centrifugated for 30 min 
at 4 °C at maximum speed and the supernatant, the lysate, was transferred to a new tube 
for subsequent westernblot analysis. 
 
 
3.2.3.3 Bradford assay for protein concentration in cell lysates 
The Bradford assay relies on the absorbance shift of the dye Coomassie Brilliant Blue 
G-250 upon binding to different amino acids, which can be detected by a plate reader 
101. 
A BSA standard with concentrations ranging from 167 mg/ml to 3000 mg/ml was 
prepared and 2 µl of each concentration was pipetted into a transparent 96 – well – plate 
in duplicates. The lysate samples were 10-fold diluted and 2 µl of the dilutions was 
pipetted into the plate in triplicates. The Bio-Rad Protein Assay Reagent Concentrate 
was diluted 5-fold with ddH20 and 150 µl of the resulting solution were added to each 
well of the 96 – well – plate. After 5 min of incubation at room temperature, the 
absorbance at 595 nm was measured using a Tecan M1000 Pro Infinite plate reader. 
The BSA standard values were used to produce a linear regression line in Microsoft 
Excel. If the coefficient of determination, R2, was ≥ 0.98, the line was accepted for 
further analysis of the samples. Sample concentrations were calculated with reference to 
the regression line. 
 
 
3.2.3.4 Subcellular fractionation 
To assess the subcellular localization of proteins, cytoplasmic, membrane and nuclear 
proteins were separated. For this, all buffers were taken from the Subcellular Protein 
Fractionation Kit, manufactured by Thermo Fisher. The complete procedure was 
performed on ice with precooled buffers and the centrifuges had been cooled to 4 °C. 
Cell pellet obtained after scraping the cells from 6 cm cell culture dishes were 
thoroughly resuspended in 100 µl cytoplasmic extraction buffer (CEB), supplemented 
with proteinase inhibitor (PI) at a 1:100 dilution. The sample was incubated in an 
overhead tumbler for 20 min at 4 °C, centrifuged for 8 min at 800 rcf and the 
supernatant was transferred to a fresh tube before being centrifuged for 10 min at 21130 
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rcf. The resulting supernatant, which was kept on ice until analysis by westernblot, was 
the cytoplasmic extract (CE). 
The pellet was washed with 800 µl ice-cold PBS supplemented with PI at a 1:100 
dilution and centrifuged for 8 min at 800 rcf. The pellet was resuspended in 100 µl 
membrane extraction buffer (MEB), with added PI and incubated for 20 min in an 
overhead tumbler. Afterwards, the samples were centrifuged for 10 min at 3000 rcf. The 
supernatant was transferred to a new tube and centrifuged for 10 min at maximum 
speed. The resulting supernatant was the membrane extract (ME), which was kept on 
ice until further analysis by westernblot. 
To reduce contamination of the nuclear extract (NE), the pellets were washed with 800 
µl PBS supplemented with PI at a 1:100 dilution, centrifuged for 10 min at 3000 rcf. 
Afterwards, the pellets were thoroughly resuspended in nuclear extraction buffer (NEB), 
supplemented with PI, vortexed for 15 sec and incubated in an overhead tumbler for 45 
min. Then, the samples were centrifuged for 10 min at 5000 rcf and the supernatant was 
transferred to a fresh tube that then was centrifuged for 10 min at maximum speed. This 
supernatant equaled the nuclear extract (NE) and kept on ice until further analysis by 
westernblot. 
 
 
3.2.4. Preparation of samples for microscopy 
 
3.2.4.1 Epi-fluorescence microscopy 
After protein incubation (see chapter 3.2.2.4), the coverslips were transferred from the 
parafilm to 6-well-plates with the membrane sheets facing up. They were then fixed by 
incubation with 4 % PFA in PBS for 20 min, shaking gently. Since PFA creates 
background fluorescence, it needed to be quenched. For this, the solution was replaced 
by 50 mM NH4Cl in PBS for 30 min, shaking gently. Afterwards, the quenching 
solution was removed, and the coverslips were washed three times for 5 min with 2 ml 
PBS. The GFP-constructs could be imaged immediately afterwards. Coverslips that 
were to be subjected to immunostaining were blocked in 2 ml 3 % BSA in PBS for one 
hour, shaking gently. Immunostainings were performed in a sequential manner. First, 
the antibody against the SBP-tag was diluted 1:50 in 3 % BSA in PBS and the 
coverslips were incubated with 100 µl of this solution for 1 h face down on parafilm in a 
wet chamber. Afterwards, they were transferred back to the 6-well-plate, washed 3 
times for 5 min with 2 ml PBS and then incubated with 100 µl of secondary antibody 
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solution, diluting the antibody as indicated in Table 10 in 3 % BSA in PBS, for 1h face 
down on parafilm in a wet chamber. Prior to use, the antibody solution was centrifuged 
for at least 10 min at 21130 rcf. After washing the coverslips in 6-well-plates three 
times for 5 min with 2 ml PBS, the entire staining procedure was repeated with the 
antibodies against the EGFR or the TFR, respectively. Coverslips were stored at 4 °C in 
PBS overnight. 
 
3.2.4.2 STED microscopy 
The coverslips were fixed, quenched and subjected to immunostaining as described in 
chapter 3.2.4.1. For membrane staining, the coverslips were incubated for 10 min with 2 
ml of a dilution of 400 µg/ml FastDiO in PBS, which had been sonicated for at least 15 
min. Then, the coverslips were washed 3 times for 5 min with PBS. The coverslips were 
mounted onto microscope slides face down in 15 µl ProLong Gold Anifade Mountant 
solution and left to dry in the dark for 24 hrs. Afterwards, the rims of the coverslips 
were sealed using clear nail polish to prevent the sample from drying out. After the nail 
polish had hardened, the coverslips could be stored at 4 °C for several weeks. 
 
3.2.4.3 Confocal microscopy 
About 25000 cells were seeded per glass coverslip located in 24-well-plates. The next 
day, the medium was exchanged by medium without FCS to starve the cells overnight. 
The following day, for stimulation, the starvation medium was exchanged by 500 µl 
medium containing 50 ng/ml EGF and the cells were incubated for 20 min at 37 °C. 
Fixation of the cells was achieved by adding to the 500 µl medium an additional 500 µl 
of 8 % PFA in PBS to each well and incubation at 37 °C for 15 min. Then, the 
coverslips were washed three times with PBS. For permeabilization, the PBS was 
replaced by 500 µl 0.5 % Triton X-100 in PBS. After 20 min incubation at room 
temperature, the coverslips were washed three times for 5 min with PBS. Then, the 
coverslips were blocked with 5 % Goat Serum and 0.3 % Triton X-100 in PBS for 1 h at 
room temperature. Having washed the coverslips three times for 5 min with PBS, the 
coverslips were transferred face up to a wet chamber and incubated with 50 µl primary 
antibody diluted in PBS containing 0.3% Triton X-100, as indicated in Table 10, per 
coverslip overnight at 4 °C. 
The primary antibody solution was removed from the coverslips and they were washed 
by dipping them consecutively into three beakers containing PBS. Per coverslip, 50 µl 
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of secondary antibody diluted in 1 % Goat Serum and 0.3 % Triton X-100 in PBS was 
pipetted onto each coverslip and they were incubated for 1 hour at room temperature in 
the dark. The secondary antibody solution was removed, and the coverslips washed 
consecutively in three beakers containing PBS. For nuclear staining, 50 µl DraQ5, 
diluted 1:1000 in PBS was added to each coverslip that were incubated for 15 min in the 
dark before the coverslips were washed again. Then, the coverslips were mounted face 
down on microscopic slides, dried overnight in the dark and stored at 4 °C. 
 
 
3.2.4.4 Cell Voyager 
6500 cells in 100 µl medium were seeded per well of a 96-well plate and grown 
overnight. On the next day, the cells were either incubated with the compounds of 
interest or directly fixed. Fixation and nuclear staining was achieved by addition of 100 
µl of a 1:2000 dilution of DraQ5 in 8 % PFA in PBS to each well and incubation for 15 
min at 37 °C. Afterwards, the medium was replaced by PBS and the plates were stored 
at 4 °C in the dark. 
 
3.2.5 Microscopy 
 
3.2.5.1 Epifluorescence microscopy 
The coverslips were placed face up in a microscopy chamber and covered with 2 ml of a 
1:10 dilution of a saturated TMA-DPH solution in PBS. If colocalization analysis was 
planned, 100 µl of a 1:1000 dilution of Tetraspeck beads was added to the imaging 
solution. 
Imaging was performed with a 60x oil immersion objective employing an additional 4x 
magnification lens.  
The membrane sheets for imaging were chosen in the TMA-DPH channel based on their 
quality and integrity. Subsequently, the images in the fluorescent channels were taken. 
GFP and Alexa 488 fluorescence were detected using the EGFP filter set, Alexa 594 
fluorescence was imaged employing the TRITC filter set and the Tetraspeck beads were 
imaged additionally with the Cy5 channel filter set. For every set of experiments, the 
image acquisition parameters such as exposure time and gain were kept constant. 
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3.2.5.2 STED microscopy 
The membrane sheets were selected for imaging based on their quality and integrity by 
evaluation of the FastDiO staining which was excited with a pulsed 488 laser and 
detected with the 500-520 nm filter. For super-resolution imaging, a pixel size of 15 nm 
x 15 nm was used. The Atto647N fluorophore was excited with a pulsed 640 nm laser 
(1.95 mW), depleted with a 775 STED laser (2.57 mW) and detected with the 620-720 
nm filter set. For the Alexa594 fluorophore, a pulsed 561 nm excitation laser (1.81 mW) 
and de-excited by a 775 STED laser (2.58 mW) was used. Its fluorescence was detected 
using the 580-630 nm filter set. The time-gate width was 8 ns with a delay of 1.094 ns 
for the line accumulation of the Alexa594 signal and a delay of 1.172 ns for the 
Atto647N signal. The width of the pinhole was set to 25 µm. 
 
 
3.2.5.3 Confocal microscopy 
The cells were selected for imaging based on their morphology. GFP fluorescence was 
excited by the 488 nm laser and the emitted signal was collected using the 525/40 nm 
filter set. DraQ5 staining was imaged by excitation with the 640 nm laser and detection 
with the DAPI/Cy5 dual dichroic mirror (MHE 46660). The Alexa594 fluorophore was 
excited by the 562 nm excitation laser and imaged using the 650-720 nm filter set. 
Confocal images were obtained using the 40x oil immersion objective (0.11 µm/pixel), 
while the 20x low working distance objective (0.459 µm/pixel) was used for the bright 
field images. 
 
 
3.2.5.4 Cell Voyager 
The automated confocal microscope was operated by Dr. Philip Denner. A 20x water 
immersion objective with a magnification of 0.75 was employed. GFP fluorescence was 
excited with a 488 nm excitation laser and detected using the 522-535 nm filter set. 
DraQ5 was excited by the 561 nm laser and the fluorescence was detected employing 
the 600-637 nm filter set. 
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3.2.6 Image Analysis 
 
3.2.6.1 Epi-fluorescence 
The images were exported as TIF files using the Olympus imaging software. All further 
analysis was performed using the open source ImageJ software version 1.51. The 
images were stacked and the channels overlaid. Square regions of interest (ROIs) with a 
size of 50 pixels were defined in the TMA-DPH channel based on the membrane quality 
and integrity. 
For determination of the mean fluorescence intensity, background ROIs were defined in 
the regions without membrane and the mean fluorescence intensity measured in the 
background ROIs was substracted from the mean fluorescence intensity in the 
membrane ROIs. 
For colocalization studies, the overlaid channels were manually aligned employing the 
Tetraspeck beads as points of reference. 
The macros “Gero_coloc_ROIs_in_composite_stack_corrected_160314_B” as well as 
“Gero_coloc_ROIs_in_composite_stack_corrected_160314_B_flip”, both written by 
Dr. Jan Gero Schloetel (AG Lang), were employed to calculate the pixel-wise PCC by 
correlating the red and green fluorescence signals of each pixel within the ROIs. Since it 
has to be ensured that the PCC of samples with high cluster density significantly differs 
from the PCC calculated from a ROI with the same cluster density but random 
distribution, the second macro flips the second channel vertically as well as horizontally 
and then determines the PCC.  
 
 
3.2.6.2 STED microscopy 
Images were exported in the TIF format by the Imspector software version 0.14.11640. 
Image analysis was performed using the open source ImageJ software. The regions of 
interest (ROIs) were set manually with reference to the membrane staining documenting 
the integrity of the membrane. For further analysis, several macros written by Dr. Jan 
Gero Schloetel (AG Lang) were employed. First, the macro 
“combine_ROIs_03_simple” was used to alternate the ROIs on the membrane with 
those in the background.  
Next, the macro “macro_gero_spot_analysis_NN_v46_FWHM_1Dvar_update2” was 
employed to perform the nearest neighbor analysis as well as the cluster size and 
density calculations. This macro first finds the local maxima in the two channels, 
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enhances spot identification by employment of a mexican hat filter and then removes 
very weak spots based on the minimum ratio of their intensity divided by their intensity 
in the other channel to address channel crosstalk. Subsequently, the nearest neighbor 
distances between the identified spots within as well as between the channels and the 
full-width at half maximum of the individual spots are calculated. 
 
 
3.2.6.3 Cell Voyager 
For image analysis the freeware software CellProfiler version 2.1.1 was employed. 
Using an algorithm written by Dr. Christoph Möhl (Image and Data Analysis Facility, 
DZNE), the software separated the nuclei from the cytoplasm in the images and 
measured the mean intensities in these regions. Since not the absolute fluorescence 
intensity, but the ratio between nuclear and cytoplasmic fluorescence was used for 
analysis, no background correction was needed. Exemplarily, one of the images after 
segmentation is shown in Figure 9. 
 
Figure 9: Example for automated cellular segmentation. DraQ5 staining of HeLa 
cells. Nuclei and cytoplasms are recognized and separated by an algorithm of the 
CellProfiler software. The bleedthrough of the DraQ5 staining into the cytoplasm was 
used to determine the cell border. 
The automatized segmentation was controlled by eye and, if necessary, corrected 
manually. 
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4 Results 
The spatiotemporal regulation of small GTPase activity is crucial for a plethora of 
cellular pathways. To achieve this, the activity as well as localization of GEFs like 
ARNO need to be controlled intricately. It has been shown that cytoplasmic ARNO is 
recruited to the inner leaflet of cell membranes via Arf1/6 and Arl4 30. The fact that 
ARNO contains a pleckstrin-homology (PH) domain which binds to 
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] and to phosphatidylinositol 3,4,5-
trisphosphate [PI(3,4,5)P3] indicates that ARNO can bind to the membrane independent 
of Arf 1/6 and Arl4 via phosphoinositide interaction 102. Since the amount of PIP2 is 
elevated in the plasma membrane as compared to other cellular compartments, a 
preferential recruitment of ARNO to the plasma membrane may be mediated by PIP2 40. 
Moreover, the availability of PIP2 binding sites may be regulated by the second 
messenger Ca2+ that has been shown to crosslink PIP2 molecules 103. Previous studies 
aimed for elucidating the binding of ARNO to artificial PIP2-containing membrane 
systems, neglecting the complexity of native membranes 28,102. Therefore, we wanted to 
study the contribution of the different ARNO domains to membrane binding on intact 
plasma membranes. These were prepared by unroofing HeLa cells with a brief 
ultrasound pulse leaving a basal plasma membrane sheet on the coverslip with the 
intracellular side facing up. This method preserves the composition of the membranes 
and avoids the need for detergents or other harsh treatments. Such membrane sheets 
have been proven to maintain many native functionalities from exocytosis to formation 
of endocytic vesicles 104,105. 
 
 
4.1 Ca2+ impairs binding of ARNO to plasma membrane sheets 
To verify that PIPs may play a role in membrane binding of ARNO and on top of that 
are regulated by Ca2+, we first tested whether Ca2+ has any influence on the binding of 
ARNO to the native membranes. It should be noted that Ca2+, even in traces, can 
mediate biological responses. To ensure Ca2+ concentrations lower than 100 nM, 
chelators like EGTA were added. First, we generated membrane sheets from Hela cells 
in a buffer without EGTA and incubated them for 5 min at room temperature without 
EGTA with 1 M recombinant ARNO that carried a green fluorescent protein (GFP) 
tag. Then membranes were fixed and imaged. As shown in Figure 10 a, there is only a 
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minor amount of GFP-fluorescence (i.e. ARNO binding) detectable on membrane 
sheets. This observation suggests that the abundance of binding sites for ARNO is either 
very scarce or that the accessibility to the binding sites is limited. 
 
 
Figure 10: EGTA treatment increases ARNO-GFP recruitment to the plasma 
membrane. Membrane sheets were prepared by a 0.1 sec ultrasound pulse at 4 °C and 
incubated with 1µM ARNO-GFP or only buffer for 5 min at room temperature. In the 
upper panel the TMA-DPH-staining is shown to document membrane integrity, the 
GFP-intensity can be seen in the lower panel. a) From left to right: Buffer control 
without ARNO-GFP, preparation of sheets and incubation with ARNO-GFP in the 
absence of the chelating agent EGTA, presence of 10 mM EGTA during the sheeting 
process as well as the protein incubation, presence of EGTA during sheeting but not 
protein incubation (≈ 30 sec), sheeting with EGTA, additional supplementation of the 
EGTA-free protein incubation buffer with CaCl2. b) Quantification of the effects, shown 
is the mean ± SEM (n = 3-6 biological replicates) normalized to the condition without 
EGTA. GFP-fluorescence is scaled equally, membrane staining arbitrarily. Scale bar: 
10 µm. 
 
For instance, as PIP2 is a signaling molecule, most PIP2 in a resting cell may be already 
occupied by other PIP2-binding molecules and thus inaccessible for the added ARNO. 
Alternatively, the PIP2-molecules might be inaccessible due to formation of PIP2-
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bridges, a phenomenon where Ca2+ ions tightly coordinate PIP2-molecules. Henceforth, 
PH-domain-containing proteins cannot bind as easily to the PIP2-molecules 103,106. 
To disrupt such putative bridges, we supplemented the buffers with EGTA. EGTA is a 
strong Ca2+ chelator and able to extract Ca2+ from the preparation, either directly from 
the membrane or from the buffer solutions that may contain traces of Ca2+ or other 
bivalent cations. Addition of EGTA to the buffer in which the membrane sheets were 
prepared as well as to the buffer in which they were incubated with the recombinant 
ARNO-GFP produced a > 25-fold increase in ARNO fluorescence intensity compared 
to the EGTA-free experiment. Albeit to a much lesser extent, binding could be also 
increased adding EGTA only to the sonication solution (where membranes spend  30 s 
after sonication, followed by another 30 s washing step without EGTA) but omitting it 
from the ARNO binding buffer. This increase was reversed when adding excess Ca2+ to 
the ARNO binding buffer as shown in Figure 10 b. 
Taken together, these data show that the accessibility of ARNO binding sites in the 
plasma membrane is limited but can be greatly enhanced by removal of bivalent cations 
such as Ca2+ which may increase the accessibility to PIP2. This observation hints to a 
crucial role of the PH-PIP-interaction in recruiting ARNO to the plasma membrane. 
 
 
4.2 The ARNO PH-domain is required, but not sufficient for membrane 
binding 
Having discovered the conditions for optimal ARNO recruitment to the plasma 
membrane sheets, we tested two protein constructs for further investigation of the role 
of the PH-PIP2-interaction for the membrane binding of ARNO. In one of the constructs 
a point mutation, changing the amino acid arginine 280 to cysteine (R280C), renders it 
incapable of binding to PIP2 28,107. The other one is a deletion construct where only the 
PH-domain, without the rest of ARNO, binds to the membrane sheets. 
In Figure 11 a and c, the fluorescence intensities of the ARNO protein constructs are 
shown. In this case, for visualization antibody-labeling of an N-terminal SBP-tag was 
employed. The PH-domain alone binds about 90 % less compared to the full–length 
ARNO. To exclude that this is caused by the SBP-tag of this short construct being 
embedded too deeply in the membrane to be accessed by the antibody, thus diminishing 
staining, we repeated this experiment employing GFP-labeling. As shown in Figure 11 
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b and d, the extent of binding diminishment was in the same range, excluding limited 
antibody accessibility as a cause for less immunostaining. 
The R280C mutant was almost completely incapable of binding to the sheets (Figure 11 
a & c). 
 
 
Figure 11: Role of the PH-domain in membrane recruitment. Having prepared the 
plasma membrane sheets in sonication buffer, they were incubated with the indicated 
ARNO protein constructs. The GFP-constructs could be imaged directly, the SBP-
tagged proteins were subjected to immunostaining. a & b) The lower panel depicts the 
SBP- or GFP-tag-signal, respectively. In the upper panel, the TMA-DPH-staining is 
shown as a control for the membrane integrity. c & d) Quantification of the signal 
intensities normalized to the full-length constructs, shown is the mean ± SEM 1 (n = 3-5 
biological replicates). All images are scaled equally in the respective channels. Scale 
bar: 10 µm 
 
Together with the observation that Ca2+, which crosslinks PIPs, diminishes ARNO 
binding, these data strongly indicate that the interaction of ARNO´s PH-domain and 
PIP2 is crucial for binding to the plasma membrane. However, the fact that the PH-
domain itself is only able to bind to a small extent points to a more complex binding 
mechanism, perhaps at a cooperative binding of the different ARNO domains. 
Therefore, the PH-PIP-interaction is essential but not sufficient for membrane 
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association of ARNO. This is in agreement with the previous studies employing 
artificial membrane systems 28,102. 
 
 
4.3 The different ARNO domains bind to the plasma membrane in a 
cooperative manner 
As previous studies have focused on the cooperative effect of the PH-domain and the 
polybasic region (PBR) 28,102, we wanted to systematically elucidate the possible 
contributions of all protein sections and therefore designed a variety of different ARNO 
constructs. A schematic overview of these constructs is shown in Figure 12. ARNO is 
comprised of the CC-domain, which can interact with other proteins and is responsible 
for dimerization, the Sec7 domain, which is the catalytically active part of the GEF, the 
PH-domain, which can interact with phosphoinositides as well as Arf proteins and the 
PBR-domain, which can bind to negatively charged lipids. 
 
Figure 12: Overview of the different ARNO protein constructs. Abbreviations: CC = 
coiled-coil-domain, Sec7 = seven-coiled-seven-domain, PH = pleckstrin-homology-
domain, PBR = polybasic region, GFP = green fluorescent protein, Lz = Leucine 
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zipper, GST = glutathione-S-transferase, SBP = streptavidin-binding-peptide. The 
∆CC-GFP and GST-PH-PBR-GFP constructs were kind gifts by Volkmar Fieberg. 
 
Because ARNO´s function is defined by the Sec7-domain, we first focused on the Sec7-
domain. We found that the Sec7-domain alone does not bind to the membrane sheets 
(Figure 13 a and c). The E156K point mutant of the full-length protein produces a loss 
of function of the Sec7-domain because this mutant is unable to coordinate the Mg2+ ion 
in the Arf GDP/GTP-binding groove and therefore cannot catalyze the release of GDP 
that is necessary for the activation of Arfs 24. This construct binds to the membrane 
sheets as strong as the wildtype protein, demonstrating that the catalytic activity of the 
Sec7-domain is not involved in recruitment of ARNO to the membrane sheets (Figure 
13 a and c). 
However, the PH-Sec7 segment binds two-fold stronger than the PH-domain alone, 
which indicates some contribution of the Sec7-domain to the membrane binding affinity 
(Figure 13 b & d). Deletion of the PBR segment (∆PBR-GFP) reduces binding by 
about 35 % and deletion of the coiled-coil-domain (∆CC-GFP) leads to a loss of more 
than 60 % of the binding (Figure 13 b & d). To determine whether the contribution of 
the coiled–coil-domain to membrane binding was a result of protein–protein-
interactions or of an increase in avidity achieved by ARNO dimerization via the coiled–
coil domain, we fused the weakly binding Sec7-PH-GFP construct with the leucine 
zipper of Gcn4 (Lz-Sec7-PH-GFP). This leucine zipper, as does the CC-domain, 
promotes dimerization of the construct but does not interact with the binding partners of 
the genuine coiled–coil domain of ARNO. This increases the binding by about 3-fold 
and may hint to an avidity-based contribution of the coiled-coil-domain (Figure 13 b & 
d). To further investigate this, we replaced the CC-domain as well as the Sec7-domain 
with the constitutively dimerized glutathione S-transferase (GST-PH-PBR-GFP). Here, 
the Sec7-domain was replaced to keep the domain composition and size more similar to 
ARNO. This construct exhibited about 80 % membrane binding affinity as compared to 
ARNO (Figure 13 b & d), which supports the suggestion that dimerization might 
stabilize membrane anchoring via the PH-domain. 
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Figure 13: All ARNO domains contribute to membrane recruitment. Membrane sheets 
were incubated with 1µM of the indicated protein constructs. GFP-fluorescence was 
imaged directly, while SBP-tagged constructs were subjected to immunostaining. The 
integrity of the membrane sheets was verified by staining with TMA-DPH. a) 
Representative images of the membrane sheets (upper panels) and the SBP-tagged 
protein constructs bound to the membrane sheets (lower panel). b) Representative 
images of the membrane sheets (upper panels) and the GFP-tagged proteins bound to 
the membranes. c & d) Quantification, shown is the mean ± SEM (n = 3-6 biological 
replicates) normalized to the signal of full-length ARNO. All images are scaled equally 
for each fluorescence channel, membrane stainings are scaled arbitrarily. Scale bar: 10 
µm. 
 
In conclusion, we show that all ARNO domains, namely PH, Sec7, PBR and CC 
contribute to binding to the plasma membrane. It is of note, that the effects are not only 
additive, but cooperative. In the case of the CC-domain, dimerization of the protein may 
be the mechanism underlying the increase in binding. 
 
 
4.4 Endogenous EGFR clusters colocalize with bound recombinant SBP-
ARNO 
Comparing the membrane stainings to the staining patterns of the constructs, it becomes 
obvious that the recombinant proteins do not uniformly bind to all membrane locations. 
Instead, they prefer special sites resembling microdomains. 
We tested whether these microdomains may be defined by protein clusters formed by 
the EGF receptor. The EGFR was selected for the following reasons: 
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First, several studies have shown that EGFR clustering is influenced by PIPs 60,62. Since 
ARNO binds to PIPs, it may be recruited to PIPs which are enriched at sites of EGFR 
clusters. 
Second, several indications point to a direct interaction between ARNO and the JM-
domain of the EGFR 108,109. 
Third, ARNO may be involved in EGFR signaling 39. 
To elucidate whether ARNO binds to EGFR clusters, we costained the membrane-
bound SBP-tagged ARNO protein constructs and the endogenous EGFR. 
Here, it should be noted that there is accumulating evidence pointing to quality issues 
concerning antibodies. Insufficient industrial validation standards and high batch-to-
batch variation contributes to a shockingly high number of non-reproducible results. 
This problem has been coined the “reproducibility crisis” 110–112. 
To ensure the specificity of the EGFR antibody used in our experiments, Dr. Jeff 
Hannam (AG Famulok) labeled the EGFR small molecule inhibitor PD168393 with the 
fluorophore Alexa594 (MH-50). This tool was used as a standard for the EGFR 
antibody validation. Membrane sheets were then costained with the EGFR antibody SC-
03 as well as the fluorescent inhibitor and colocalization was assessed. Exemplary 
images are shown in Figure 14. 
 
 
Figure 14: Validation of the EGFR antibody. Epifluorescent images of HeLa 
membrane sheets stained for the EGFR costained with the SC-03 antibody (green) and 
the Alexa-594-labeled inhibitor PD168393 (MH-50, red). Overlay of the two channels 
results in the intermediate color yellow for almost all EGFR clusters. The calculated 
PCC equals 0.82. n = two biological replicates including about 60 membrane sheets, 
SD ± 0.007. 
 
Visual analysis of the resulting stainings already suggests a high degree of overlap. The 
Pearson Correlation Coefficient of 0.82 provided the mathematical verification of this 
impression. It should be noted, that a value of 0.82 suggests a nearly perfect overlap as 
for technical limitations always lower values than 1 are found even in the case of perfect 
colocalization 113. 
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Consequently, we concluded that the used batch of SC-03 antibody indeed selectively 
and specifically stained the EGFR. 
The results of the costaining of the SBP-ARNO constructs and the EGFR are presented 
in Figure 15.  
Visual examination of the images reveals a great extent of overlap between the EGFR 
and the full-length protein as well as the E156K mutant. For the other constructs, no 
cluster overlap is obvious at least by visual examination. 
Colocalization between two fluorophores consists of two components: Co-occurence, 
that is the presence of both fluorophores within individual pixels, and correlation which 
means proportional codistribution of two probes 114. Subjectively, colocalization can be 
identified visually by superimposing the two image channels. However, the gained 
insight is qualitative at best and poses the additional problem that an intermediate color, 
for example yellow for the combination of a red and green channel, can only be 
observed if the intensities of the fluorescence signals are in a comparable range 115. In 
the Pearson Correlation Coefficient (PCC) analysis, the intensities of red and green 
fluorescence are measured for each pixel to determine the correlation coefficient across 
a region of interest. In the case of perfect correlation, the PCC equals +1, no correlation 
results in a PCC of 0 and a PCC of -1 indicates an inversely related distribution of 
probes 116. 
While interpretation of PCC values in absolute terms of overlap is difficult, it serves as 
an indicator for relative colocalization between the different protein constructs. It also 
should be noted that colocalization is no evidence for a direct protein-protein 
interaction. It only hints to an either direct or indirect interaction between the two 
proteins or just spatial proximity. As shown in Figure 15 b, the PCC between the EGFR 
clusters and recombinant SBP-ARNO bound to the sheets equals approximately 0.3, 
indicating a significant but not strong correlation. The SBP-PH construct colocalizes 
with the EGFR to a weaker extent of about 0.18 which may be due to the lower binding 
affinity of the PH-domain alone. However, the difference between the PCC values of 
the two constructs is statistically significant (student´s t-test, p = 0.009). This suggests 
that the colocalization between SBP-ARNO and the EGFR is not only due to the 
proximity between the EGFR clusters and PIP2 62. 
For the SBP-tagged E156K point mutant approximately the same PCC as for full-length 
ARNO is obtained indicating that exchange function of the Sec7 domain is not 
necessary for the spatial proximity of ARNO and the EGFR. 
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The recombinant SBP-R280C mutant as well as the SBP-Sec7-domain do not exhibit 
colocalization with the endogenous EGFR clusters, which is not surprising since these 
constructs hardly bind to the membrane. Compared to the PH-domain, which displays 
roughly 10 % of the intensity, the Sec7-domain and the R280C mutant are in a range of 
1–2 % what may preclude the detection of overlapping structures.  
 
Figure 15: Colocalization of SBP-ARNO constructs and the endogenous EGFR. 
Membrane sheets were incubated with a 1 µM solution of SBP-tagged ARNO 
constructs, before being subjected to sequential immunostaining against the SBP-tag 
(Alexa 594, third panel) and the endogenous EGFR (Alexa 488, second panel). The 
membrane sheet integrity was controlled by staining with TMA-DPH during imaging 
(first panel). The overlay of the EGFR and the ARNO channel is shown in the fourth 
panel. a) Representative images of the stainings for the EGFR (green), the different 
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SBP-tagged protein constructs bound to the membrane (red) and the overlay of the two 
fluorescence channels (yellow). b) The Pearson Correlation Coefficient indicates the 
extent of colocalization between endogenous EGFR and SBP-tagged ARNO protein 
constructs. Shown is the mean ± SEM (n = 3-8 biological replicates). Statistical 
analysis: Student´s t-test. Scale bar: 5 µm. 
 
 
4.5 The spatial proximity of SBP-ARNO and EGFR clusters is not an 
artefact of cluster density 
The resolution of conventional epifluorescence microscopy is limited by the Abbe 
diffraction limit, which defines the minimal distance two objects must have to be 
separated from each other. This distance is dependent on the wavelength of the light and 
the numerical aperture of the microscope objective. In practice, this distance ranges 
between 200 – 300 nm. Therefore, two objects, e.g. an EGFR cluster and an ARNO 
binding site, overlapping in epi-fluorescence microscopy may be separated from each 
other by more than 100 nm, which would exclude a direct molecular interaction 
between the EGFR and ARNO. To reduce this uncertainty, we employed super-
resolution microscopy 117. 
On immunostained samples the distances between EGFR clusters and the sites to which 
SBP-ARNO binds were analyzed. 
For this, an ImageJ Macro programmed by Dr. Jan Gero Schloetel (AG Lang) was used 
that first sharpens the raw images by application of a Mexican Hat Filter to then localize 
the clusters´ centers by their fluorescence intensity maxima. Only clusters for which the 
Gaussian fit obtained an R2 ≥ 0.9 were included in the analysis. Then, the software 
calculates the distances between one channel´s maxima and the closest maximum in the 
respective other channel. As a reference channel, the SBP-ARNO signal is employed so 
the distance from SBP-ARNO binding site to the next EGFR cluster is calculated.  
To determine the distances at randomized cluster distribution at the given density, the 
analysis was as well performed after the EGFR channel had been flipped horizontally 
and vertically, in the following referred to as “flip ctrl” analysis. 
In Figure 16 b the distance distribution histogram between the SBP-ARNO sites and 
their adjacent EGFR cluster is shown. To exclude that the observed proximity was 
rather the consequence of the number of EGFR clusters per area than an indication of an 
attraction between ARNO and EGFR clusters, we performed the nearest neighbor 
analysis with the endogenous Transferrin receptor (TFR) which has approximately the 
same cluster density as the EGFR (Figure 16 d & g). The histogram of the flip control 
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for the Transferrin receptor is shifted to the right (Figure 16 d, black), but the 
difference between the flipped and unflipped (turquoise) distance distribution 
histograms is not as pronounced as for the EGFR nearest neighbor analysis (Figure 16 
b) In other words, the distance distribution of SBP-ARNO has a stronger resemblance 
of the random distribution for the TFR analysis than for the EGFR analysis. 
An overlay of the distance distribution histograms for SBP-ARNO clusters in relation to 
the EGFR (magenta) and the Transferrin receptor (turquoise) is shown in Figure 16 e. 
Clearly, the latter histogram is shifted to the right which indicates a smaller population 
of SBP-ARNO clusters in close and a larger population in further distance to the next 
endogenous TFR cluster. 
 
 
Figure 16: Comparison of the nearest neighbor analysis between SBP-ARNO and the 
EGFR or Transferrin-Receptor (TFR), respectively. a/c) Representative confocal 
images of membrane sheets stained with Fast-DiO (left panel) and STED images of 
SBP-ARNO (red) and the EGFR or TFR (green) (middle panel) and magnified image 
sections (right panel). b) Frequency distribution of distance between SBP-ARNO and its 
nearest EGFR clusters (magenta) d) Frequency distribution of the distances between 
SBP-ARNO clusters and the TFR clusters (turquoise). Flip ctrl shown in black. e) 
Direct comparison of the distance distributions between ARNO and the EGFR 
(magenta) and TFR (turquoise), respectively. f) Percentage of ARNO clusters per ROI 
that are closer than 45nm to their next neighboring EGFR cluster or the next TFR 
cluster, respectively. Mean values are shown ± SEM. g) Cluster densities of EGFR and 
TFR. Three biological replicates with 11 – 15 ROIs per day were included into the 
analysis. 
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As seen in Figure 16 f, performance of the nearest neighbor analysis of SBP-ARNO 
and the TFR and comparing it to the previous analysis with the EGFR reveals that less 
than 20% of SBP-ARNO clusters are closer than 45 nm to their next TFR neighbor 
compared to the about 30% of clusters closer than 45 nm to the neighboring EGFR 
cluster. Even though employment of the student´s t-test for statistical evaluation did not 
proof this difference to be significant (p = 0.068), the power of the test was very low 
due to the low n of three. This is synonymous with a high probability of a false negative 
testing result. 
Analysis of a randomized cluster distribution (flip ctrl) accounts for approximately 10% 
of the neighbors in very close proximity. Subtraction of this value leads to the result that 
SBP-ARNO sites are twice as often closer than 45 nm to the next EGFR than they are to 
the next TFR cluster. 
Conclusively, the control of the nearest neighbor analysis with the Transferrin receptor 
supports the presumption that the overlap of SBP-ARNO and endogenous EGFR 
clusters exists due to a molecular interaction, being it direct or indirect, and not due to 
random spatial distribution and cluster densities. 
 
 
4.6 STED imaging suggests that many ARNO clusters bind very close to the 
EGFR 
Having determined the proximity distribution of SBP-ARNO and the EGFR, the nearest 
neighbor analysis was performed for the other ARNO constructs. The STED images as 
well as the nearest neighbor distance distribution histograms are depicted in Figure 17. 
In all cases a peak at around 40 nm distance was observed, which was most prominent 
for SBP-ARNO and SBP-E156K, which is expected from the epifluorescence data (see 
Figure 13). Different from the overlap determined in epifluorescence microscopy, the 
differences between the constructs was more subtle, suggesting that binding of all 
constructs occurs in principle to the same locations. Because constructs lacking domains 
bind with a lower affinity, the reduction of their PCC is more pronounced. Except for 
the SBP-R280C construct, the median distance values for all protein constructs are 
approximately 75 nm and the histograms visualize similar median distances. In all 
cases, the median distance of the flip control, shown in black, was significantly larger 
than for the sample, shown in magenta, indicating that the spatial cluster distribution is 
not random. 
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Minor differences in their distribution can be explained by the different signal densities. 
While for SBP-ARNO more than 3500 clusters could be analyzed, only 450 SBP-
R280C clusters were included into the analysis (Table 18). 
 
Table 18: Number of clusters per SBP-protein construct analyzed in nearest neighbor 
analysis 
Protein construct Number of clusters analyzed 
SBP-ARNO 3554 
SBP-E156K 3260 
SBP-Sec7 713 
SBP-R280C 450 
SBP-PH 1007 
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Figure 17: Nearest Neighbor analysis between the EGFR and membrane-bound 
recombinant SBP-ARNO-constructs. Membrane sheets were incubated with a 1 µM 
solution of SBP-ARNO-construct for 5 min before PFA fixation, quenching and 
immunostaining. Membranes were stained with Fast-DiO and selected for analysis 
based on membrane integrity (for exemplary images see Figure 16). The nearest 
neighbor analysis was performed using an ImageJ-Macro written by Dr. Jan Gero 
Schloetel (AG Lang). Scale bar: 1 µm. a) The left panel shows the STED images of 
recombinant ARNO constructs (red) and endogenous EGFR clusters (green). b) In the 
right panel, histograms of the distance distributions of the nearest neighbor analyses for 
the different SBP-ARNO constructs (magenta) with flip controls (black) are presented. 
Three biological replicates were pooled, resulting in 450 (SBP-R280C) to 3554(SBP-
ARNO) analyzed clusters. 
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Altogether, the high-resolution image analysis narrows down the minimal distance 
between EGFR and ARNO binding site to a value smaller than 45 nm: A close 
proximity of EGFR and SBP-ARNO clusters can be observed and quantified. While 
being a prerequisite for an interaction, existence or even the nature thereof is not 
addressed. 
 
 
4.7 Physical size of the clusters 
Cluster sizes were determined to clarify whether the short distances between the centers 
of the SBP-ARNO and EGFR clusters may indicate physical contact between clusters. 
As schematically depicted in Figure 18 a, cluster sizes were defined as the full width at 
half-maximum (FWHM) of the Gaussian fit to the clusters´ intensity profiles 118,119. 
 
 
Figure 18: Size determination of EGFR and SBP-ARNO clusters. a) Schematic 
representation of a cluster´s fluorescence intensity profile (magenta, dotted line). 
Cluster diameters were determined by measurement of the full width at half maximum of 
two Gaussian fits with different line widths of the individual clusters. b) Frequency 
distribution histograms of the FWHM of the endogenous EGFR clusters (black) and c) 
SBP-ARNO (magenta). Three biological replicates were pooled for the analysis, for the 
EGFR 2621 and for SBP-ARNO 3554 clusters were analyzed. 
 
Figure 18 b shows that the size distribution of the EGFR clusters has a rather narrow 
profile with a mean of 65 nm ± 14 while the histogram of SBP-ARNO´s size 
distribution is slightly broader and has a mean of 78 nm ± 25. 
Therefore, distances between EGFR and SBP-ARNO clusters closer than 71.5 nm, 
which equals the sum of the cluster radii, may indicate binding that both proteins locate 
to the same membrane structure or that two different entities exist that are in physical 
contact. 
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4.8 The fraction of ARNO/ARNO construct clusters closer than 45 nm to 
EGFR clusters is the same for all constructs 
Having observed similar nearest neighbor distance distribution histograms for the SBP-
tagged protein constructs (Figure 17), we took a closer look at the clusters with a 
distance closer than 45 nm. The reasoning for choosing this value was two-fold. First, 
the distance distributions have a peak at this value, indicating the existence of a defined 
population. Second, such distances indicate close physical proximity even for the very 
small clusters. 
In a defined region of interest (ROI), the number of ARNO/ARNO-construct clusters 
with an EGFR cluster closer than 45 nm was expressed as percentage of all clusters 
(Figure 19 a). 
 
 
Figure 19: Portion of SBP-construct clusters in very close proximity to the EGFR 
clusters. a) The number of spots per region of interest that are closer than 45nm to the 
next endogenous EGFR cluster. b) The percentage of spots per ROI that are nearer than 
45nm to an EGFR cluster. Flip controls are depicted in black. Three biological 
replicates with 15 ROIs each were included in the analysis. Shown are mean values ± 
SEM. 
 
Interestingly, Figure 19 a shows that the percentage of clusters closer than 45 nm to its 
next EGFR neighbor is in the same range for all constructs. Comparison with the flip 
control, shown in black, reveals that this percentage of approximately 30 % is about 
three times as high as for randomly distributed clusters. 
Consequently, in case of a binding event between ARNO and the EGFR, all domains 
might be contributing to the interaction by fitting into distinct binding sites. 
Note that, due to the different binding efficiencies, the number of ARNO/ARNO 
construct clusters varied largely between the constructs (Table 18) and so does the 
RESULTS 
 
62 
absolute number of clusters which are closer than 45 nm to their next EGFR cluster per 
ROI (Figure 19 b). 
 
 
4.9 Impairment of ARNO-GFP membrane binding by EGFR antibodies 
Close proximity of proteins can lead to mutual exclusion of their antibody staining in 
double staining experiments. Likewise, this fact can be explored to test whether two 
proteins are close to each other. Hence, we assessed whether binding of ARNO-GFP to 
the membrane sheets could be impaired by coincubation with antibodies against the 
EGFR. Three different antibodies against the EGFR, namely CS4267, PA1-1110 and 
SC-03, were added to the ARNO-GFP solution at a dilution of 1:100. The incubation 
time was 5 minutes. As a control, an antibody against the Transferrin receptor was used 
because the Transferrin receptor has the same cluster density as the EGFR (Figure 16 
b), so this antibody is supposed to decorate the membrane sheets equally well as the 
EGFR antibody. 
Figure 20 shows that there is a trend for decreased ARNO-GFP binding to the 
membrane sheets in all conditions to which EGFR antibody had been added. Addition 
of the primary antibody against the TFR does not decrease binding. 
 
 
Figure 20: Competition of ARNO-GFP with EGFR antibodies. Membrane sheets were 
incubated with 1µM ARNO-GFP in either buffer or a 100-fold dilution of EGFR 
antibody for 5 min. As a control, the antibody against the Transferrin receptor is 
employed. The sheets were imaged on the day of the experiment. a) Representative 
images of the different conditions. Membrane integrity was controlled with TMA-DPH 
staining (upper panel). The GFP-signal is shown in the lower panel. All images are 
scaled equally in the GFP channel and arbitrarily in the TMA-DPH channel. b) 
Quantification of the effect, shown is the mean ± SEM (n = 3-4 biological replicates). 
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The result of this competition binding experiment provides an additional hint that a 
fraction of ARNO and EGFR proteins are very close to each other on the plasma 
membrane. 
 
 
4.10 The staining pattern of the EGFR is altered only after SBP-ARNO 
binding 
As previously described (Figure 15), for the colocalization study, the membrane sheets 
were incubated with different SBP-tagged ARNO constructs for five minutes, 
subsequently fixed with PFA and quenched of background fluorescence with 50 mM 
NH4Cl. Then, they were stained for the SBP-tag before being incubated with the SC-03 
antibody against the EGFR and its secondary antibody. 
Interestingly, the staining intensity of the EGFR is influenced depending on which 
protein construct the membrane sheets were incubated with. Figure 21 a illustrates the 
EGFR intensity normalized to the buffer control. Incubation with SBP-ARNO led to a 
more than 1.2-fold increase in EGFR stainability. SBP-E156K also increases the EGFR 
staining intensity, though the effect is not as pronounced as for the wildtype. A Kruskal-
Wallis one-way analysis on ranks treating each sheet as a replicate calculates a p value 
smaller than 0.001 for both conditions. Incubation with the SBP-R280C construct, 
decreases the staining intensity of the EGFR, significantly (Kruskal-Wallis one-way 
analysis p = 0.016). The other ARNO protein constructs do not have an effect. At first it 
might be surprising that ARNO-binding does not lead to a diminished binding, because 
of the decrease of ARNO binding upon coincubation with EGFR antibodies (Figure 
20). 
A plausible reason for this might be a conformational change of the flexible C-terminal 
tail of the EGFR making it more accessible for the SC-03 antibody after ARNO 
binding. Alternatively, incubation with ARNO might lower the packing density of the 
EGFR clusters, which could decrease steric hindrance of antibody binding thus leading 
to an increase of staining intensity. 
The coefficient of variation, or Relative Standard Deviation (RSD) can serve as a 
measure for the degree of clustering or cluster size. In our case, it is defined as the 
standard deviation of the signal within the membrane ROI σ divided by the mean 
fluorescence intensity μ 120: 
𝑅𝑆𝐷 =  
𝜎
𝜇
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After incubation with SBP-ARNO or SBP-E156K, the RSD of the EGFR is 
significantly lowered (Kruskal-Wallis one-way analysis, p < 0.001), indicating a lower 
degree of clustering of the EGFR molecules. In contrast, the RSD is increased after 
incubation of the sheets with SBP-R280C (Kruskal-Wallis one-way analysis, p < 0.001) 
(Figure 21 b). 
 
 
Figure 21: Influence of ARNO constructs on EGFR staining intensity and clustering. 
The sheets were incubated for 5 min with either buffer or 1 µM of the SBP-tagged 
protein construct, and immunostained against the SBP-tag followed by immunostaining 
for the EGFR. Analysis is performed on the data already presented in Figure 15. a) 
Intensity of the EGFR staining values normalized to the buffer condition. b) The relative 
standard deviation (RSD) of the EGFR clusters, shown is the mean ± SEM (n = 3-8 
biological replicates). The values are normalized to the buffer condition. 
 
Altogether, the analysis of the EGFR staining pattern suggests that ARNO influences 
the arrangement or conformation of EGFR molecules. 
 
 
4.11 Influence of SecinH3 on membrane recruitment of SBP-ARNO and 
clustering of the EGFR 
Being one of the small GEFs for Arf 1&6, ARNO is insensitive to Brefeldin A. 
However, it can be inhibited by the small molecule inhibitor SecinH3 as could be shown 
in a variety of studies 25,121,122. We tested in how far addition of SecinH3 during 
incubation of the sheets with the SBP-ARNO affects the ability of SBP-ARNO to bind 
to the membrane. 
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Indeed, as shown in Figure 22, incubation with 15 µM SecinH3 impairs the ability of 
ARNO to bind to the sheets which is indicated by a decrease in signal intensity as 
compared to the DMSO control (Rank Sum test, p < 0.001, see panel a). In good 
agreement with the results described in Figure 21, inhibition of ARNO leads to a 
decrease in EGFR staining intensity or, in other words, a loss of ARNO mediated 
increase (Rank Sum test, p = 0.02, panel b) and a higher degree of clustering (Rank Sum 
test, p = 0.021, panel c). 
 
 
Figure 22: Effect of SecinH3 on ARNO binding and EGFR staining pattern. The 
membrane sheets were incubated for 5 min with 1 µM SBP-ARNO either in the presence 
of 0.4% DMSO or 15µM SecinH3 before being immunostained subsequently for the 
SBP-tag and the EGFR. Shown are mean values ± SD (n = 3 biological replicates, 98 
SBP-ARNO and 96 SecinH3 membrane sheets). a) The intensity of the ARNO staining is 
decreased upon coincubation with SecinH3. b) The EGFR intensity is decreased to 
about 90% after treatment with SecinH3 during SBP-ARNO incubation. c) The EGFR´s 
RSD is slightly increased for the sheets treated with 15 µM SecinH3 during the 5 min of 
protein incubation. 
 
This is especially interesting, since the GTPase-inactive mutant E156K does not behave 
differently from the wild-type ARNO in terms of binding and influence on the EGFR. 
Thus, this is a hint at another functional relationship between ARNO and SecinH3 or 
between the Sec7–domain of ARNO and the EGFR. 
Altogether, the data support the notion that incubation with ARNO influences the EGFR 
clustering and/or its conformation. However, it should be noted that this does not prove 
a direct interaction. 
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4.12 Overexpression of ARNO in HeLa cells leads to a trend for stronger 
activation of the EGFR 
Having observed a colocalization with and possible influence on the clustering of the 
EGFR, we aimed at investigating in how far changes in the intracellular ARNO 
concentration might impact the EGFR´s activation to determine a possible functional 
relevance of the findings. 
As a measure for receptor activation, we chose the phosphorylation status of Tyrosin 
1086, because it is known to be phosphorylated in early receptor activation and serves 
as an important binding site for downstream effectors like the Cbl-Grb2-complex 123. 
HeLa cells were transfected with different amounts of an ARNO–coding plasmid, 
starved overnight in medium without FCS, stimulated with 50 ng/ml EGF for 5 min, 
lysed and analyzed via Westernblot. 
A representative example of these Westernblots is shown in pseudocolor in Figure 23 
a. As expected, the EGFR content is decreased upon stimulation of the cells (upper 
panel) 124. Phosphorylation of the tyrosine residue 1086 is greatly enhanced after 
stimulation. A tendency for a further increase of phosphorylation in the cells transfected 
with 1µg or 2µg ARNO-plasmid can be observed as well (second panel). In the bottom 
panel, the ARNO blot is shown, indicating that the transfection of the ARNO strongly 
increases the ARNO concentration strongly above the endogenous level. The 
quantification of the pY1086 bands normalized to the EGFR content and the loading 
control Lamin is shown in Figure 23 b. 
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Figure 23: Influence of the overexpression of ARNO on EGFR activation. HeLa cells 
were transfected with a plasmid coding for ARNO, grown for 24h starved overnight, 
stimulated and analyzed by westernblot. A transfection of empty plasmid (mock) was 
included as a reference. a) Westernblot in pseudocolor (blue: low signal intensity, red: 
high intensity). EGFR phosphorylation, indicated by staining against pY1086 (second 
panel) increases upon stimulation with EGF. The gel loading control Lamin (third 
panel) is shown only for one of the blots. The transfection-dependent increase of the 
cells´ ARNO content can be seen in the bottom panel. b) Quantification of Westernblot 
bands. EGFR and pY1086 signals were normalized to their respective Lamin loading 
control yielding pY1086/Lamin and EGFR/Lamin. Finally the pY1086 was divided by 
EGFR/Lamin. Shown are mean values ± SEM (n = 5-7 biological replicates). 
 
For the cells transfected with 1 µg or 2 µg ARNO plasmid, the mean values are about 
30 % higher than that of the Mock transfected cells. However, the signal variability 
between the different days is quite high so that statistical testing does not prove this 
tendency to be significant (Kruskal-Wallis-test on ranks; p = 0.935). Transfection of 4 
µg ARNO plasmid did not alter phosphorylation of the tyrosine residue 1086 much 
compared to the Mock transfected condition. 
Even though a tendency towards a correlation between intracellular ARNO 
concentration and an enhanced EGFR activation can be observed, it does not hold up to 
rigorous statistical testing. 
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4.13 Immunostaining reveals nuclear translocation of the EGFR after 
stimulation with EGF 
Full-length EGFR originating from the plasma membrane within the nucleus has been 
observed in a variety of tissues, tumors and cancer cell lines. Nuclear translocation of 
the EGFR has been reported to be initialized by stimulation with growth factors like 
EGF, irradiation in radiotherapy or treatment with EGFR antibodies 125. One method to 
analyze this is the immunostaining of the EGFR with antibodies prior to microscopic 
imaging. 
Here, we employ immunostaining of the EGFR with two different antibodies (CS4267 
& SC-03) to show the EGFR´s translocation into the nuclei of HeLa cells. Exemplary 
images of Hela cells that had been starved overnight, optionally stimulated with 50 
ng/ml EGF for 20 minutes, fixed, permeabilized and stained for the EGFR (red) as well 
as the nuclei (blue) are seen in Figure 24. Unstimulated cells (upper rows) are 
compared to stimulated cells (lower rows). These images taken by a CLSM are the 
central optical sections of stacks that were recorded from the top to the bottom of the 
nuclei to ensure that possibly observed intranuclear EGFR staining is not due to out of 
focus fluorescence from above or below the nuclei. 
In the left panels, the EGFR staining is depicted (a: stained with CS4267, b: stained 
with SC-03). Strikingly, the staining pattern of the two antibodies differs greatly. This 
might be yet another example of the limitations of commercial antibodies and the lack 
of validation by the producers and distributors. However, for both staining conditions, 
vesicular internalization upon stimulation can be observed. 
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Figure 24: Detection of EGFR by immunofluorescence before and after stimulation. 
HeLa cells were starved overnight and either left unstimulated or stimulated with 
50ng/ml EGF for 20 minutes, fixed with 3.7% PFA and immunostained for the EGFR 
(red, left panel) and the nuclei (blue, middle panel). An overlay of both channels is 
shown in the right panel. a) The EGFR was stained with the CS4267 antibody. b) EGFR 
staining with the SC-03 antibody. Scale bar: 10µm. For each staining, the red channel 
is scaled equally. The experiment was performed twice. 
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Both EGFR antibodies detect a strong stimulation-dependent accumulation of EGFR in 
the perinuclear periphery. Occasionally, some spots appeared to be present within the 
nuclei. 
 
 
4.14 Subcellular fractionation of HeLa cells hints at nuclear translocation of 
the EGFR 
Having found preliminary evidence for the EGFR´s nuclear translocation by 
fluorescence microscopy, we wanted to verify this result by cellular fractionation. For 
this, HeLa cells were starved overnight, stimulated with 50 ng/ml EGF for 5 minutes or 
left unstimulated and underwent subcellular fractionation by cell lysis using buffers 
with different salt concentrations and centrifugation, yielding three fractions: cytoplasm, 
membrane and nucleoplasm. 
 
 
Figure 25: EGFR distribution analyzed by subcellular fractionation. Subcellular 
fractionation of Hela cells that, after overnight starvation, were either left unstimulated 
(U) or stimulated with 50 ng/ml EGF for 5 min (S). a) Westernblot of the obtained 
extracts. EGFR (upper panel), Lamin (middle panel) as a marker protein for the 
nuclear fraction and GAPDH (bottom panel) as the marker for the cytoplasmic extract. 
b) Quantification of the EGFR divided by the total EGFR content. The data of each 
extract was normalized to its unstimulated condition, shown are the mean values ± SEM 
(n = 7 biological replicates). Statistical analysis: Rank Sum test performed with values 
before normalization, p = 0.383 for the nuclear extract. 
 
Figure 25 a shows a representative westernblot of the subcellular fractionation. In the 
upper panel the EGFR signal is shown. The middle panel indicates the nuclear filament 
Lamin to control for the destruction of nuclei in earlier fractionation steps, what does 
not seem to happen to a great extent. The cytoplasmic protein GAPDH is blotted to 
check for spillover from the cytoplasmic extract into the other fractions. 
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Though additional washing steps were added to the kit protocol, some spillover is 
observed. However, since it happened to the same extent for both conditions, it is not 
considered to distort the result. 
Stimulation-dependent decrease of the EGFR is seen in the cytoplasmic extract, which 
probably is the result from translocation as well as degradation. A double band appears 
in the nuclear extract and both bands were included in quantification. This double band 
has regularly been observed in our experiments and could, for example, originate from 
different phosphorylation patterns.  
A quantification of the portion of the EGFR in the different fractions is depicted in 
Figure 25 b. In the mean, the proportion of nuclear EGFR in stimulated cells is about 
1.5 times higher than in unstimulated ones. However, the variance between the different 
days was too high to withstand statistical testing (Rank Sum test, p = 0.383). Yet, the 
double band in the stimulated cells´ nuclear extract is a clear sign for changes in nuclear 
EGFR content. 
 
 
4.15 The role of ARNO in the nuclear translocation of the EGFR 
We asked whether ARNO regulates EGFR translocation to the nucleus. The rational for 
this was two-fold: First, the three clusters of basic amino acids (RRRHIVRKRTLRR) 
within the EGFR´s JM-domain were identified as its nuclear localization sequence 
(NLS) and the JM-domain was identified as a putative binding region for ARNO 108,126. 
Second, EGFR nuclear translocation can be triggered by its activation through EGF 
stimulation and we had observed a tendency for increased EGFR phosphorylation after 
ARNO transfection (see Figure 23). 
 
 
4.15.1 Overexpression of ARNO has no influence on the nuclear translocation of 
the EGFR 
HeLa cells were transfected with different amounts of ARNO plasmid, starved serum-
free overnight, stimulated with 50 ng/ml EGF for 5 min and subjected to subcellular 
fractionation before being analyzed by westernblot. In Figure 26 a, a representative 
westernblot is shown. For all stimulated conditions, a characteristic double band can be 
observed in the nuclear extract. However, no clear differences between the cells that had 
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been transfected with empty vector (Mock) and the ones transfected with different 
ARNO concentrations can be observed. 
 
 
Figure 26: Influence of the overexpression of ARNO on the nuclear translocation of 
the EGFR. Subcellular fractionations were performed after transfection with empty 
vector (Mock) or different amounts of ARNO and stimulation with 50 ng/ml EGF for 5 
min. a) Western blot of the EGFR content of the different extracts. EGFR content of the 
cytoplasmic extract (upper panel), membrane extract (middle panel) and nuclear 
extract (bottom panel). b) Quantification of the ratio of nuclear EGFR to total EGFR 
content, normalized to the Mock-transfected. Depicted is the mean value ± SEM (n = 3 
biological replicates). 
 
This visual observation is underlined by quantification and statistical analysis of the 
westernblots which is shown in Figure 26 b. Neither does the one-way Anova analysis 
detect a significant difference between the conditions (p=0.597), nor is a clear tendency 
observed. 
 
 
4.15.2 Establishment of reporter cell lines for the nuclear translocation of the 
EGFR 
We set up a system allowing to reproduce the basic finding, that the JM-domain is 
responsible for the nuclear translocation of the EGFR. 
A schematic depiction of the constructs used for further analysis is shown in Figure 27 
a: Since GFP is known to accumulate in the nucleus, the cytoplasmic protein pyruvate 
kinase (PK) was chosen as a component of the fusion constructs to ensure a clear 
distinction between the cytoplasmic protein construct and the one that is actively 
imported into the nucleus. It was either coupled to a monomeric GFP protein (PK-GFP, 
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left) or to the monomeric GFP and the EGFR´s JM-domain (PK-JM-GFP, right). So, we 
suspected the first protein construct to be located cytoplasmatically and the latter one to 
be translocated into the nucleus. 
To assess and quantify this, we used the automated high throughput confocal imaging 
platform Cell Voyager for image acquisition and employed the Cell Profiler Software 
for analysis. As a measure for the extent of nuclear localization of the fusion proteins, 
we calculated the Nuclear Localization Index (NLI) as a ratio of the fluorescence signal 
within the nuclei (NFI) divided by total fluorescence being the sum of the fluorescence 
intensity within the nuclei plus the fluorescence intensity within the cytoplasm (CFI): 
 
𝑁𝐿𝐼 =
𝑁𝐹𝐼
𝑁𝐹𝐼 + 𝐶𝐹𝐼
 
 
The values of the NLI can range from 0, indicating a completely cytoplasmic protein 
localization and +1 which means a 100 % nuclear localization. 
Figure 27 b shows representative images of the stable cell lines. In the upper row of 
pictures, epifluorescent and in the bottom row confocal images are presented. For each 
cell line the GFP channel (left panel), the nuclear DRAQ5 staining (blue, middle panel) 
and the overlay of the two (right panel) is shown. The cell line expressing PK-GFP is 
shown on the left and the cytoplasmic localization can be observed distinctly. On the 
other hand, the PK-JM-GFP fusion protein is clearly located predominantly in the cells´ 
nuclei (right side). 
The relative frequency distributions of the cell lines´ Nuclear Localization Indices are 
shown in Figure 27 c. For the cell line stably transfected with the PK-GFP fusion 
protein (left), the distribution has a relatively sharp peak with a maximum of about 0.5 
and a mean value of 0.48 ± 0.04. The unexpectedly high content of nuclear PK-GFP can 
be explained by two phenomena: First, the correct subcellular localization of proteins 
might be obscured by overexpression, a phenomenon which has been described before 
127, and, secondly, since the nucleoplasm has a smaller volume than the cytoplasm, a 
given amount of nuclear fluorescent protein has a bigger effect on the NLI than the 
same amount of protein would have when located in the cytoplasm. 
On the right side, the frequency distribution histogram of the cell line stably transfected 
with PK-JM-GFP is shown. Clearly, a population right from the one of PK-GFP can be 
observed. The NLI values of this cell line have a mean value of 0.64 ± 0.08. 
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Figure 27: The NLS is located in the JM-domain of the EGFR. Stable Hela cell lines 
were created by transfection of the different constructs and subsequent selection of the 
cells with Zeocin. The cells were fixed with 3.7% PFA, permeabilized and the nuclei 
were stained with DRAQ5. Analysis was performed with the Cell Profiler Software. a) 
Schematic representation of the transfected constructs. The cytoplasmic protein 
pyruvate kinase was fused to mEGFP (PK-GFP, left side) as a control. Secondly, the 
EGFR´s JM domain was inserted into the pyruvate kinase-mEGFP fusion protein (PK-
JM-GFP, right side). b) Microscopic images of the PK-GFP cell line (left) and PK-JM-
GFP (right). Depicted is the GFP-channel, the DRAQ5-channel and the overlay of the 
two. In the upper row epifluorescent (scale bar 40 µm) and in the lower row confocal 
images (scale bar 10 µm) are shown. c) Relative frequency distributions of the cells´ 
localization indices. Higher values indicate a higher proportion of intranuclear protein. 
On the left side, the PK-GFP´s histogram has a mean value of 0.48 ± 0.04. The PK-JM-
GFP´s mean value equals 0.64 ± 0.08 (right side). (Two biological replicates, 171 and 
283 cells were analyzed). 
 
Conclusively, we were able to reproduce Hsu and Hung´s findings and found an 
analysis that is able to read out and quantify differences in subcellular protein 
localization. 
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4.15.2.1 Transfected ARNO-mCherry is not cotranslocated into the nuclei with the 
EGFR 
Since the JM-domain has been reported to interact with ARNO, we assessed whether 
ARNO might be cotranslocated into the nucleus together with the PK-JM-GFP 
construct. Therefore, ARNO-mCherry was transfected into the HeLa reporter cell line. 
Exemplary confocal images are shown in Figure 28. 
 
 
Figure 28: Localization of ARNO co-expressed with PK-JM-GFP. Confocal images of 
the fixed Hela cell line stably expressing PK-JM-GFP (green, left panel). The cellular 
localization of the transiently transfected ARNO-mCherry (red) is cytoplasmic. Nuclei 
are shown in blue, an overlay of all three channels can be seen in the far-right panel. 
Scale bar 5 µm. 
 
Despite the clear nuclear localization of the JM-domain-containing protein construct, 
the cytoplasmic localization of ARNO-mCherry is maintained. 
 
 
4.15.2.2 Influence of Importazole on the subcellular localization of PK-GFP and PK-
JM-GFP 
To take a closer look at the mode of nuclear translocation of the EGFR and to evaluate 
in how far the stable cell lines are a sensitive and suitable readout for change thereof, 
we employed two different small molecule inhibitors and assessed their influence on the 
subcellular localization of the established protein constructs. 
Previous studies found that the EGFR colocalizes and interacts with Importin α/β, a 
class of proteins that directly interact with nucleoporins thus mediating the transport of 
cargo through the nuclear pores 128,129. The 2,4-diaminoquinazoline compound 
Importazole has been described as a membrane-permeable small molecule capable of 
interrupting Importin-mediated nuclear import 130,131. Consequently, we incubated the 
HeLa cell lines stably expressing PK-GFP or PK-JM-GFP with either 63 µM 
Importazole or 0.4 % DMSO for 10 hours.              
RESULTS 
 
76 
A distinct effect on the relative frequency distribution of the Nuclear Localization Index 
of the cell line transfected with PK-JM-GFP, but not the one transfected with PK-GFP 
is observed (Figure 29 a & b): The PK-JM-GFP cell line´s histogram is shifted towards 
smaller NLIs indicating a profoundly reduced proportion of nuclear protein. In fact, a 
peak can be observed around 0.52 which is approximately the mean value of the cell 
line expressing PK-GFP. These data support the hypothesis that the construct containing 
the EGFR´s JM-domain, and therefore its NLS, is imported into the nucleus in a 
controlled and regulated way while the nuclear presence of the PK-GFP is most 
probably only an overexpression artefact. 
 
 
Figure 29: Influence of Importazole on PK-GFP and PK-JM-GFP. Frequency 
distribution histograms of the stable cell lines after treatment with Importazole. a) HeLa 
cells stably expressing PK-GFP were treated with either DMSO (red) or Importazole 
(blue). b) Treatment of the PK–JM-GFP cell line with Importazole (blue) in comparison 
to the cells that have been treated with DMSO only (black) (2 biological replicates, 
between 101 and 283 cells per condition).  
 
In summary, the dependency on Importin for nuclear import could be reproduced and 
measured with our reporter cell lines. 
 
 
4.15.3 Influence of Secin compounds on the nuclear translocation of the EGFR 
Since incubation with SecinH3 is able to reverse the impact of recombinant ARNO on 
endogenous EGFR clusters in plasma membrane sheets (Figure 22). we consequently 
addressed the impact of incubation with 15 µM SecinH3 prior to stimulation on the 
subcellular localization of the EGFR. 
The westernblot in Figure 30 a shows the subcellular fractionation of the analyzed 
HeLa cells. From left to right, the EGFR signals of starved, unstimulated (U), 
stimulated cells that had been treated with 0.4 % DMSO (S) and cells that had been 
incubated with 15µM SecinH3 prior to stimulation (H3) are shown.          
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By visual examination of the westernblot bands, no difference between the DMSO 
control and the condition treated with SecinH3 can be noticed. 
 
 
Figure 30: Influence of SecinH3 on the nuclear translocation of the EGFR. 
Subcellular fractionation of starved and stimulated HeLa cells that had been either 
incubated with 15 µM SecinH3 or 0.4 % DMSO. a) Representative westernblot of the 
different fractions of unstimulated cells (U), cells that have been stimulated with 50 
ng/ml EGF for 5 min (S) and cells that have been incubated with 15 µM SecinH3 prior 
to stimulation (H3). b) Quantification of the ratio of nuclear EGFR to total EGFR 
normalized to the DMSO control. Depicted are the mean values ± SEM, normalized to 
the stimulated DMSO ctrl. Statistical test: Student´s t-test, difference between DMSO 
and SecinH3 not significant (p = 0.724). 3-4 biological replicates. 
 
This observation is verified by quantification and statistical analysis of the westernblot 
signal, which is seen in Figure 30 b. Analysis of the ratio of nuclear EGFR to total 
cellular EGFR reveals almost no difference in the mean value. This is reflected in the 
student´s t-test p-value of 0.724. 
To verify and extend this finding, we once again employed the Cell Voyager system for 
assessment of a variety of Secin compounds´ influence on the subcellular distribution of 
PK-GFP or PK-JM-GFP, respectively. Subsequently, for every imaged cell, the Nuclear 
Localization Index (NLI) was calculated and analyzed. 
In Figure 31 a, the resulting frequency distribution histograms for the cell line stably 
expressing the PK-GFP fusion protein and in panel b the ones for the cell line 
expressing PK–JM-GFP are depicted. 
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Figure 31: Treatment of PK-GFP and PK-JM-GFP cell lines with Secin compounds. 
Frequency distribution histograms of the Nuclear Localization Indices of the cell lines 
stably transfected with PK-JM-GFP or PK-GFP, respectively after incubation with 
either DMSO (black/red) or a Secin compound (shades of green). a) Frequency 
distribution histograms of the PK-JM-GFP-transfected cell line´s NLI. b) Frequency 
distribution histograms after incubating the PK-GFP-transfected cell line with different 
Secin compounds. 1 biological replicate, between 84 and 184 cells analyzed. 
 
None of the compounds has a discernible effect on either of the cell lines what is in line 
with the other findings. 
Overall, in this study, no influence of ARNO on the nuclear translocation of the EGFR 
could be observed. 
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5 Discussion 
 
5.1 Membrane binding of ARNO 
In the first part of this study, we assessed the contribution of the different domains of 
ARNO to plasma membrane binding, since this recruitment is required for many of 
ARNO´s major functions. Among these functions, the activation of the small GTPase 
Arf6 that in turn does not only recognize and bind to preferred sites of effector proteins 
but assembles them into multi-valent membrane-binding platforms held together by 
multiple protein-membrane and protein-protein interactions, is well established 132. 
Consequently, vesicle formation and packing as well as membrane remodeling is 
initiated 19. On top of that, Arf6 is involved in cytoskeletal rearrangement thus playing a 
role in cell migration and adhesion 133.  
 
 
5.1.1 The role of the ARNO coiled-coil domain 
Active participation in recruitment of ARNO to the plasma membrane from the 
cytoplasm has, for example, been reported for Arf6 and Arl4. Membrane-associated 
Arf6 and Arl4 molecules can bind to ARNO´s PH-domain. The cooperative binding of 
the PH-domain to Arf6 as well as PIP2 is thought to relieve the autoinhibition of ARNO 
thus leading to the activation of more Arf proteins 134. 
However, in some cases ARNO does not freely translocate between cytoplasm and 
plasma membrane but has been reported to be actively shuttled towards the plasma 
membrane, for example bound to CCDC120 in vesicles of growing neurites 135. 
As described, Arf can be activated by directly recruiting ARNO. Besides this direct 
interaction of ARNO and Arf, sometimes the activation is mediated by third party 
proteins like RLIP1 or CNK1 136,137. Binding to these proteins has been shown to be 
conveyed by ARNO´s coiled-coil-domain. 
The coiled-coil domain is structurally similar to a leucin zipper and can therefore 
interact with other proteins containing similar domains as well as lead to 
homodimerization 138. 
In agreement with the findings reporting the facilitation of membrane recruitment by 
coiled-coil domain-binding proteins like CNK1, as indicated in Figure 13, we found 
that loss of the coiled-coil domain impaired ARNO´s binding of the basal plasma 
membrane by approximately 60 %. 
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ARNO´s preference for dimerization due to its coiled-coil domain has clearly been 
demonstrated 139. Artificial dimerization of a Sec7-PH-GFP-construct by a leucin zipper 
was able to restore the membrane binding ability in part, but not totally. Dimerization of 
the PH-PBR-construct by fusion with GST lead to a similar result (Figure 13). This 
suggests that the coiled-coil domain´s contribution to membrane binding might be partly 
due to the interaction with other proteins and partly due to an increased avidity 
facilitating the protein-membrane-interaction for the other domains. 
Contradictory, Hiester and his colleagues performed subcellular fractionations and 
found less full-length ARNO in the membrane fraction than of an ARNO construct 
lacking the coiled-coil domain. They then performed several bead-based binding assays 
and concluded that the coiled-coil domain bound to the other ARNO domains adding 
yet another autoinhibitory mechanism impairing membrane binding 32. However, 
neither did they control for equal expression levels of the transfected protein constructs, 
nor does their model of autoinhibitory coiled-coil domain-binding take the coiled-coil 
domain´s role in dimerization of ARNO into account. 
 
 
5.1.2 The availability of PIP2 for PH-domain-containing proteins 
Since our data cement the importance of the PIP-PH-domain-interaction for plasma 
membrane binding of ARNO (Figure 11), it is self-evident that the availability of PIPs 
for binding is an important factor for ARNO´s plasma membrane association. 
Regulation of the availability of PIPs for their binding partners is strictly regulated in a 
spatio-temporal manner. This is a prerequisite for the coordinated orchestration of the 
many signaling pathways PIPs are involved in. Since studies have shown that the total 
concentration of PIP2 does not change much in response to extracellular stimuli, this 
regulation seems to be achieved largely independent from synthesis and turnover 141. 
Interestingly, one of the key regulators of the amount of free PIP2 in the plasma 
membrane is the concentration of intracellular cations such as Ca2+ and Mg2+. 
However, many different mechanisms come into play determining the influence of these 
cations. On the one hand, the anionic head groups of the PIP2 molecules attract cations 
from the cytoplasm forming an ionic double layer. This ion cloud electrostatically 
shields the PIPs from their potential binding partners.  
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For example, intracellular Mg2+ and other multivalent cations can decrease the 
interaction between certain K+-channels (KCNQ) and PIP2 and even impair the 
membrane recruitment of rat Synaptotagmin-1 106,142. Furthermore, a phenomenon 
called “Ca2+-PIP2-bridges” has been coined, a very strong binding between Ca2+-ions 
and the anionic head groups of PIP2 molecules preventing the interaction of PH-
domains and PIP2. The biological relevance of the Ca2+-dependent inhibition of the 
membrane recruitment of PH-domain-containing proteins has been shown in 
hepatocytes during obesity and hyperlipidemia that have a chronically attenuated Ca2+-
level 143. 
These effects on the availability of PIPs are a possible explanation for the necessity of 
the chelator EGTA in the binding assays (Figure 10) and might also explain why, after 
incubation with EGTA, such a high amount of recombinant ARNO could be bound to 
the sheets compared to the amount of plasma membrane-bound endogenous ARNO in 
steady state 36. This might also be the reason why overexpression of ARNO leads to a 
predominantly cytoplasmic localization (Figure 28), something that had also been 
observed before 144.  
Compared to EDTA, EGTA has a higher sensitivity for Ca2+, but a much lower affinity 
for Mg2+. To explain why chelation of Ca2+ is more relevant for the availability of PIPs 
for binding by PH-domains than chelation of Mg2+, the physicochemical properties of 
the different cations need to be taken into consideration. Since in the aqueous solution 
of the cytoplasm the cations are surrounded by a hydration shell, formation of an ionic 
interaction or bridge requires the release of a water molecule from that shell. 
Though equal in net charge, other characteristics determine the differences in the 
energetic barriers that need to be overcome for this process. 
The coordination number defines the number of a central atom´s neighbors in a crystal 
or molecule. While Mg2+ coordinates its neighbors favorably in a strict sixfold 
octahedral complex and therefore has a coordination number of six, Ca2+ prefers 
coordination numbers between six and eight and has a wider range of energetically low 
ligand atom bond lengths 145. Since the radius of Mg2+ is smaller than that of Ca2+, its 
charge–to–radius–ratio is bigger. These factors contribute to the relatively high 
hydration energy of Mg2+ and a water exchange rate that is about 3000 times lower than 
that of Ca2+ 146. In summary, these properties may explain why Ca2+ forms tight bridges 
with the PIP2 molecules while Mg2+ associates more loosely in ion clouds. 
DISCUSSION 
 
However, it is of note that cations are not the only factors influencing the availability of 
PIPs in the plasma membrane. Myristoylated alanine-rich C kinase substrate 
(MARCKS) are natively unfolded proteins, meaning that they are not structured in a 
specific way. A single MARCKS molecule is able to nonspecifically and 
electrostatically sequester multiple PIP2 molecules. Therefore, they are able to sequester 
and concentrate pools of PIP2 in specific regions of the plasma membrane, for example 
in ruffles 147,148. This interaction is reversible. Calmodulin, that is activated by high 
intracellular Ca2+ levels, leads to dissociation of MARCKS from the membrane freeing 
the previously sequestered PIP2 molecules 149. So, in the part of the membranes in 
which PIP2 had been bound to MARCKS, elevation of the intracellular Ca2+ 
concentration results in more binding sites for PH-domain-containing proteins instead 
of less. 
Taken together, this means that the spatiotemporal fluctuations of Ca2+ concentration at 
the plasma membrane might regulate ARNO recruitment, differentially. 
 
 
5.2 Ca2+ plays a central role in the network of PIP2, ARNO and the EGFR 
Ca2+ ions have been known to ubiquitously regulate a plethora of cellular functions. Not 
only exists a concentration gradient over four orders of magnitude between the intra- 
and extracellular milieu, but tight spatiotemporal control of the intracellular Ca2+ level 
enables the cell to use this cation as a versatile tool for the specific regulation of various 
signaling pathways 140. 
 
 
5.2.1 The intracellular Ca2+ level can be regulated stimulus-dependent by the 
EGFR 
Since Ca2+ acts as such an important cofactor in cell signaling, its intracellular 
concentration is subject to intricate regulation. 
Activation of the Phospholipase C is one of the downstream effects of EGFR signaling 
150. It breaks down PIP2 into two second messengers: Diacylglycerol (DAG) and 
Inositol(1,4,5)triphosphate (IP3). IP3 diffuses into the cytoplasm, binds to specific 
receptors at the membrane of the endoplasmic reticulum which serves as the cell´s Ca2+ 
storage organelle. Consequently, a substantial amount of Ca2+ is released into the 
cytoplasm within a very short period of time.  
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This rapid increase in cytoplasmic Ca2+ concentration is downregulated by 
dephosphorylation of IP3 to IP2, phosphorylation of IP3 to IP4 and actively pumping the 
Ca2+ ions into the extracellular space. DAG on the other hand remains in the plasma 
membrane where it can either be involved in eicosanoid synthesis or activation of the 
protein kinase C (PKC) 151. 
In addition to the subsequent Ca2+ release from intracellular stores, an influx from the 
extracellular space can be triggered. The extent and proportions of these two different 
mechanisms influencing the intracellular Ca2+ concentration is dependent on the 
strength and duration of the EGF stimulus 152. Massive influx of extracellular Ca2+ 
through ion channels leads to local Ca2+ microdomains around the channel adding to the 
heterogeneity of Ca2+ concentrations across the plasma membrane 140. As already 
described in Chapter 1.6, the interaction between the EGFR´s JM-domain and PIP2 is 
crucial for the receptor´s activity. It has not yet been elucidated whether free Ca2+ ions 
can impair this interaction. Nevertheless, the Ca2+-Calmodulin-complex is able to bind 
directly to the EGFR´s JM-domain if all four Ca2+ binding sites of the Calmodulin 
molecule are occupied resulting in impairment of the EGFR–PIP2–interaction 153. On 
top of that, certain Calmodulin–dependent kinases like the CaMKII phosphorylate the 
EGFR leading to its deactivation and increased endocytosis 152. Given that the studies 
reporting that the EGFR–PIP2–interaction is required for the receptor´s activation seem 
more convincing than those claiming the opposite, the augmented Ca2+ level would lead 
to a negative feedback 47,60,62. 
 
 
5.2.2 G-protein coupled receptors are important mediators of Ca2+ signaling  
Among the most prominent regulators are G-protein coupled receptor (GPCR)-induced 
PIP2 signaling pathways. GPCRs constitute the largest family of plasma membrane 
receptors and can be activated by a multiltude of different stimuli like neurotransmitters, 
light or the extracellular Ca2+ level 154. 
Structurally, GPCRs consist of seven transmembrane units with an extracellular ligand 
binding site and an intracellular G-protein interaction surface and can be found in either 
active, active-like or inactive conformation. Ligand binding induces, in cooperation 
with other factors, the conformational change from the inactive to the active state in 
which the GPCR can act as a GEF for heterotrimeric G-proteins, exchanging bound 
GDP for GTP 155.  
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The activated G-protein then dissociates from the receptor and in turn kicks off several 
signaling pathways. One of the major ones includes activation of the Phospholipase C-β 
resulting in a pronounced increase of the intracellular Ca2+ concentration. 
 
 
5.2.3 The signaling pathways of GPCRs and small GTPases are interwoven 
It has been widely accepted that small GTPases play a role in the trafficking of GPCRs 
from the ER to the plasma membrane thus providing spatio-temporal regulation of the 
hundreds of different GPCRs. For example, inhibition of the five human Arf GTPases 
demonstrated that they differentially modulate the cell surface targeting of the GPCRs 
like the α2B-adrenergic receptor, the angiotensin II type 1 receptor and the chemokine 
receptor 4. Expectedly, manipulation of Arf1 shows the strongest effect 156. Recycling 
times and therefore resensitization vary between different GPCRs 157. 
In addition to the broad control of GPCR signaling through trafficking by small 
GTPases, there is evidence for a direct interaction between certain amino acids in the C-
terminal tail of GPCRs and small GTPases 158. This can lead to the exchange from GDP 
to GTP and therefore activation of the small GTPase and propagate signaling. 
Consequently, the GPCR has direct influence on its own trafficking. For example, the 
angiotensin type 1 receptor causes the activation of Rab5a thus increasing endocytosis. 
Rab8 is reportedly the first example for a small GTPase to influence the inositol 
phosphate signaling of the metabotropic glutamate receptor 1a (mGLuR1a) leading to 
the attenuation of the Ca2+-level in primary hippocampal neurons 159. 
Another phospholipase that can be activated by many Ca2+-mobilizing GPCRs is the 
phospholipase D (PLD). Mitchell and colleagues showed that its activation could be 
inhibited by the Arf protein inhibitor Brefeldin A and were able to coimmunoprecipitate 
Arf and Rho GTPases with certain GPCRs of the Rhodopsin family. Conclusively, they 
proposed a model in which direct interaction between GPCRs and Arf as well as Rho 
GTPases leads to a stronger activation of the PLD independently from heterotrimeric G-
proteins 160. 
Desensitization of GPCRs can be achieved by phosphorylation and subsequent binding 
of β-Arrestins. These proteins occupy the G protein binding site thus terminating active 
signaling via G-proteins. However, this initiates G-protein independent signaling 
pathways. 161. On top of that, they link the receptor to Clathrin and other endocytic 
proteins.  
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Several groups demonstrated that Arf6 as well as ARNO directly interact with and are 
regulated by GPCR-associated Arrestin β, providing a direct link between the 
desensitization of Ca2+ concentration-regulating GPCRs and ARNO 162,163. 
These findings, together with our results concerning the notion that the binding of 
ARNO to the plasma membrane strongly depends on the availability of PIP2 and can be 
impaired by the formation of Ca2+ -PIP2-bridges (Figure 10), may raise speculations in 
how far this might be a relevant positive feedback for GPCRs delaying their 
desensitization. On the other hand, in those regions of the plasma membrane where the 
PIP2 molecules had been sequestered by MARCKS, more binding sites for ARNO 
might be available leading to increased endocytosis of the GPCRs. 
Among many others, these findings sparked a discussion in the scientific field about the 
depth and extent of the crosstalk between classical GPCR and small GTPase signaling 
pathways. For Arf proteins as well as GPCRs, the view develops from the 
understanding of individual signaling molecules to members of signaling platforms in 
the membrane consisting of an ensemble of crosstalking molecules 132,164.  
 
 
5.2.4 The EGFR-GPCR relationship 
During about one and a half decades, solid evidence has accumulated that the signaling 
networks of GPCRs and the EGFR crosstalk 165. The modes of transactivation of the 
EGFR by GPCRs can basically be divided into two mechanisms: 
Firstly, many GPCRs directly increase the activity of membrane-embedded matrix 
metalloproteases (MMP). These shed ligands like HB-EGF from the membrane leading 
to the EGFR´s activation, a process that has been shown to be relevant for many 
physiological processes and diseases including cancer 166,167. 
Secondly, GPCRs can activate intracellular protein tyrosine kinases (PTK), for example 
of the Src family, promoting the phosphorylation of the EGFR 168. 
Thus, once again, the extent of complexity of the signaling pathways´ meshwork in cells 
is underlined. 
 
 
 
 
 
DISCUSSION 
 
5.3 Plasma membrane compartmentalization 
Having analyzed numerous factors that are important for ARNO´s binding to the plasma 
membrane, high resolution STED imaging provided a more detailed look at the way 
ARNO molecules are organized once they are bound. 
Generally, most proteins that are either transiently bound to or permanently integrated 
in the plasma membrane do not diffuse randomly but exist in an equilibrium between 
free monomers and clusters or microdomains, respectively. 
 
 
5.3.1 The meaning of protein clustering and micropatterning 
Our view on membranes has changed during the course of the last decades from simple 
barriers between cellular compartments to the realization that lipids actively interact 
with the integrated proteins influencing their signaling. In terms of the organization of 
proteins within membranes, by today, there is no model that covers all observed 
phenomena in their entire complexity, but a variety of non–mutually exclusive ideas, 
each highlighting certain characteristics of the system 169. 
 
 
5.3.1.1 The mobility of proteins in the plasma membrane is limited 
Initially, Nicolson and Singer had proposed the “fluid mosaic model” in which 
membranes are a viscous two-dimensional solution formed by freely diffusing lipids 
and proteins 170. However, this hypothesis was undercut by the finding that the diffusion 
of proteins in natural membranes was about 5-50 times slower than in artificial 
membranes 171. Evidence accumulated that proteins and lipids are not distributed 
homogenously and advanced techniques like single-molecule tracking led to the “picket 
fence model”. It proposes that the movement of transmembrane proteins is restricted 
into so-called “confinement zones” by cytoskeletal proteins like actin. Transgression 
from one confinement zone into the other can only happen by so-called “hop-diffusion” 
172,173. On top of that, the existence of “lipid rafts” has been claimed: Sphingolipid 
microdomains that require cholesterol and are resistant to certain detergents though their 
existence and relevance has been subject to controversy in the field 174–176. Nevertheless, 
it too supports the notion of a spatial compartmentalization of the plasma membrane 
itself. In 2006, Lillemeier and colleagues conducted electron microscopy studies of 
membrane sheets and were able to distinguish areas of high and low protein density. 
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They therefore proposed the idea of proteophilic regions in the membrane, so-called 
“protein islands” that have a diameter between 30 and 300 nm and probably develop 
due to protein-protein and protein–lipid-interactions 49.  
Within these regions, the proteins self-organize into clusters and microdomains. 
This notion would explain why our STED images do not show evenly distributed 
clusters, but regions with a high abundance of clusters and regions that were nearly 
devoid of them (Figure 16). Though relatively long-lived, clusters are fluctuating, non-
rigid structures which means that the proteins exist in an equilibrium between its 
monomeric and clustered form 177. 
 
 
5.3.2 The partial cluster overlap might indicate a functional connection between 
ARNO and the EGFR 
The STED data in (Figure 17) show that there is nearly no concentric colocalization 
between ARNO and EGFR clusters, but rather a close proximity and partial overlap. 
This neither indicates a functional relationship between the two proteins, nor does it 
exclude direct interaction. Certain interacting proteins have been shown to form clusters 
exhibiting a similar pattern. For example, the microtubule end binding protein EB1 is 
well known to interact with the tumor-suppressor protein adenomatous polyposis coli 
(APC) in non-cholinergic cells. Yet, in nicotinic synapses, confocal microscopy 
imaging revealed an only partial overlap and very close proximity of the protein clusters 
178.  
Advances in microscopic techniques like the overcome of the diffraction barrier might 
lead to an increase in this kind of findings: Clusters, which can appear to be fully 
colocalized when analyzed with confocal or wide-field microscopy might be resolved to 
only partially overlap using advanced techniques like STED or PALM/STORM 179. 
Likewise, in this study, the extent of protein cluster overlap becomes apparent in STED 
but not epifluorescent wide-field microscopy (Figure 17 & 15). 
Interestingly, the PCC as well as the STED data of the different ARNO constructs may 
indicate that the overlap of ARNO construct and EGFR clusters rather depend on the 
ability to bind to the membrane than on the presence of a certain domain. The finding 
that for all membrane-bound constructs the percentage of clusters in very close 
proximity to the EGFR is about the same (Figure 19) may indicate that a putative 
binding to the EGFR might be achieved in a cooperative manner. 
DISCUSSION 
 
The ability of EGFR antibodies to compete with ARNO for plasma membrane binding 
is an additional indication for the great vicinity between ARNO and EGFR molecules in 
the membrane (Figure 20). It makes sense that membrane binding of ARNO-GFP was 
reduced, but not inhibited since only a fraction of ARNO is expected to be very close to 
the EGFR and therefore is impaired in its ability to bind. 
 
 
5.3.2.1 What drives cluster formation? 
To get a better understanding of the colocalization of ARNO and EGFR clusters, it is 
important to understand how protein clusters are formed. 
The formation of clusters is driven by different forces: Electrostatic interactions 
between charged residues or (induced) dipoles as well as hydrophobic forces. 
For example, PIP2 sequesters the SNARE-protein syntaxin 1a by interaction with its 
positively charged polybasic region. Neutralization of the protein´s charge reduces the 
electrostatic repulsion between the proteins thus facilitating a higher packing density 180. 
Similarly, the interaction between PIP2 and the EGFR´s JM-domain is not only relevant 
for the structural conformation of its dimers, but also drives the formation of 
nanoclusters. Aberrant numbers and sizes of EGFR clusters have been found in lung 
cancer cells as compared to healthy cells suggesting a pathophysiological relevance 61. 
However, the abundance of positively charged lipids in the plasma membrane is low. 
Therefore, neutralization of negative protein residues is achieved by cations like Ca2+. 
Conclusively, supplementation of buffer with divalent cations induces protein clustering 
on membrane sheets 146. 
Hydrophobic forces probably synergistically add to the formation of clusters, for 
example due to their involvement in coiled-coil formation 181.  
Another determinant of clustering is the interaction between the membrane-associated 
and cytoplasmic proteins. 
On the one hand, specific cytoplasmic interactions have been shown to directly 
influence formation and packing density of clusters. For example, tight clustering of 
syntaxin 1A has been reported to require the protein´s cytoplasmic domain while the 
transmembrane domain is sufficient for loose packing 182.  
On the other hand, there is evidence that the density and size of the membrane´s 
confinement zones or protein islands, together with protein concentration, also is a 
factor determining clustering of transmembrane proteins like the EGFR 183. 
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Cluster size is limited, probably by short-range attractive and long range repulsive 
forces between the proteins. Abulrob and colleagues found a similar EGFR cluster size 
distribution as in this study with a mean diameter of 150 nm. Treatment with EGF 
resulted in an increased number of small and large clusters, while preincubation with 
EGFR inhibitors reversed the increase of large clusters to control cell level 118. Typical 
cluster sizes of proteins in the plasma membrane are around 70 – 100 nm, so the sizes of 
the ARNO as well as the EGFR clusters determined in this study are in the usual range 
(Figure 18) 184. This argues for a natural behavior of the added recombinant ARNO, 
since the high concentration does not lead to larger diameter, but to a higher number of 
clusters in the membrane, when compared to wildtype ARNO clusters. This 
phenomenon has also been observed for overexpressed syntaxin 1A constructs 182. 
However, the flip control that was utilized in the colocalization studies to control for 
arbitrarily close clusters, does not account for restrictions of the clusters´ spatial 
distribution in the membrane. So, employment of the flip control alone, could not 
exclude that the observed proximity between EGFR and ARNO clusters is due to 
random island distribution. Because of this, the Transferrin receptor, which has the 
same cluster density as the EGFR, has been employed as a control protein. The nearest 
neighbor analysis of STED images observes less ARNO clusters in very close proximity 
to TFR clusters (Figure 16), while the flip control values are almost equal for the TFR – 
ARNO and EGFR – ARNO analysis. Thus, the results of the EGFR–ARNO nearest 
neighbor analysis are not due to random cluster distribution. 
The Transferrin receptor mediates the endocytic intake of iron by binding to its ligand 
Transferrin. This uptake is dependent on PI(4,5)P2, so a close proximity between PIP2 
and the TFR is likely 185. Therefore, the fact that ARNO and the EGFR are closer to 
each other than ARNO and the TFR might be conveyed by more than only mutual 
sequestering by PIP2. This is especially interesting, since the group of Michel Franco 
and others observed that Arf6 and its GEF EFA6 are directly involved in endocytosis as 
well as recycling of the TFR 186,187. So, probably the close proximity between ARNO 
and the EGFR, as compared to the TFR, is not explained by binding of ARNO to Arf6. 
 
 
 
 
DISCUSSION 
 
5.3.3 The packing density of molecules within a cluster can be important for its 
functionality 
The term cluster density defines the number of packed molecules per area within a 
cluster. This packing density depends on several factors like ion concentration, the 
protein conformation that might be influenced by e.g. ligand binding, posttranslational 
modifications and sequestering by other proteins or lipids. Its physiological relevance 
has been shown, for example, for α4 integrins that mediate cell adhesion. Tightening of 
its packing density by overexpression of CD82 positively correlated with an increase of 
cell adhesion 146,188. 
Most studies focusing on EGFR clustering primarily analyzed the oligomerization state 
of the EGFR, being the ratio between monomers, dimers and oligomers. 
Since stimulation of cells with EGFR as well as the incubation with inhibitors change 
EGFR clustering, there is a general agreement, that the degree of oligomerization is 
important for its signaling 189–191. 
However, not much is known about the changes in the packing density of EGFR 
molecules within the clusters and its impact on signaling. 
The data presented in Figure 21 indicate, that incubation of the plasma membrane 
sheets with ARNO leads to a more intense antibody-staining of the EGFR. Since the 
total amount of EGFR molecules in the sheets cannot have changed, the accessibility of 
the C-terminal epitope, which is the binding site of the SC-03 EGFR antibody, must 
have increased. This might either be due to a conformational rearrangement of this C-
terminal tail or due to changes in the degree of clustering or cluster density, 
respectively. A very dense packing of the proteins can mask the epitopes impairing 
binding of antibodies and therefore reducing the fluorescence intensity 182. Thus, an 
increase of stainability might hint at looser packing of EGFR molecules. Future studies 
may elucidate the relationship between ARNO and EGFR clustering. Independent of 
whether the increased accessibility of the EGFR´s C–terminus is the result of reduced 
packing density or a conformational change, this might also be of physiological 
relevance since effector proteins such as Shc and Grb2 bind to this domain 192. If the 
increased accessibility is not only true for the antibody, but also for effector proteins, a 
physiological relevance would be probable. 
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Also, some of the other ARNO constructs do influence the EGFR clusters´ RSD. 
Similarly to the full-length ARNO, the E156K construct decreases the RSD value while 
Sec7-and PH–domain do not have a significant effect and the R280C mutant increases 
it. On the other hand, cotreatment of the membrane sheets with the inhibitor SecinH3 
reversed the effect of ARNO on the EGFR´s staining intensity and RSD (Figure 22). 
So, similar to the results concerning the colocalization with the EGFR, this influence 
seems to be dependent on the ability of the constructs to bind to the membrane. 
 
 
5.4. The functional relationship between ARNO and the EGFR 
Given the close proximity of ARNO and EGFR clusters and the influence of ARNO on 
the staining of the EGFR´s C-terminal tail, the second part of the study aimed at 
elucidating in how far ARNO and the EGFR functions are connected in a possibly 
biologically relevant way. 
 
 
5.4.1 There might be evidence for a biological influence of ARNO on EGFR 
activation 
After transfection of ARNO into HeLa cells a tendency of increased EGFR 
phosphorylation at the tyrosine residue 1086 (pY1086), and therefore activation, can be 
observed in comparison to mock–transfected cells (Figure 23). Here, increasing the 
number of biological replicates might lead to a result that withstands statistical testing. 
In human embryonal kidney (Hek) cells, the increase of EGFR phosphorylation after 
transfection with ARNO was even more pronounced (personal communication Michael 
Famulok). Therefore, the effect could be observed in a tumor as well as an immortalized 
cell line hinting at a phenomenon that might be of relevance not only in a cancer context 
but also in healthy cells. Downstream effectors like Grb2 and Cbl bind to pY1086, so 
proving an influence of ARNO on these proteins would support the ARNO – pY1086 – 
relationship suggested in this study. 
In vitro experiments assessing EGFR phosphorylation in presence or absence of ARNO 
were not able to detect differences 37. The presence of different artificial membrane 
systems like nanodiscs and bicelles did not lead to different results 108. 
In summary, the inability to detect an increase of EGFR stimulation in cell-free setups 
rather speaks for the involvement of additional players than for a direct interaction. 
DISCUSSION 
 
Therefore, future studies might aim at elucidating the effect of ARNO overexpression, 
knockout or inhibition by SecinH3 on proteins associated with EGFR signaling. 
 
 
5.4.2 There is no evidence for an involvement of ARNO in the EGFR´s nuclear 
translocation 
Given that, in a cellular context, there is a tendency for increased EGFR 
phosphorylation upon ARNO overexpression, and that the hypothetical binding site for 
ARNO in the JM-domain is congruent with the EGFR´s nuclear localization sequence, 
the question arose whether ARNO has an impact on the EGFR´s nuclear translocation 
108,126. 
While it was possible to observe the increased subcellular localization after EGFR 
stimulation with EGF in confocal microscopy as well as in westernblot analysis of 
subcellular fractionation extracts, in this study, no influence of ARNO overexpression 
or inhibiton on the nuclear translocation of the EGFR could be detected (Chapter 4.15). 
This might either be the case because there is none or due to an insensitivity of the 
analysis methods used. 
While visually, the difference in the subcellular concentration of the PK-GFP and PK-
JM-GFP constructs was strikingly apparent, the latter´s NLI was just 30 % higher. 
However, this might be because the NLI distribution histogram of the PK-JM-GFP 
expressing cell line shows a very wide population, which might blur the effect (Figure 
27). Given this narrow range of the mean NLI values between two extremely distinct 
constructs, it is possible that smaller changes might not be distinguishable. 
So, inhibition of Sec61β–mediated nuclear import by Importazole did lead only to a 
rather small shift in the PK-JM-GFP cell line´s histogram. Nevertheless, a peak could be 
observed at an NLI value of 0,52 which is close to the mean value of the PK-GFP cell 
line signifying an enrichment of protein in the cytoplasm confirming the previously 
reported involvement of Sec61β in the EGFR´s nuclear import (Figure 29) 128. 
Consequently, future research might assess in how far Importazole might be a valuable 
therapeutic agent for inhibition of nucelar import of the EGFR, for example in addition 
to radiotherapy. 
 Live cell imaging and the analysis of individual cells could be a way of improving the 
sensitivity issues because different cells within the broad population and their reaction 
to stimuli can be distinguished.  
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Also, it could be interesting to compare ARNO overexpressing cells to ARNO knockout 
cells in regards of the subcellular distribution of either the PK-constructs or the EGFR 
itself. The knockout might provide further insight, because the Secin compounds only 
inhibit the GTPase activity of cytohesin Sec7-domains so GTPase–independent 
functions might be unaffected 193. 
Hypothetically, if the lack of influence of ARNO activity on EGFR translocation is real, 
this might serve as an additional argument against the direct interaction between ARNO 
and the JM-domain since otherwise ARNO and Importin β would compete for the exact 
same binding site. However, the possibility of an interaction under special 
circumstances, e.g. a certain subcellular localization, specific stimuli etc. is conceivable. 
 
 
5.4.3 CNK 1 might be a possible third player connecting ARNO with the EGFR 
Another possible explanation for an influence of ARNO on the EGFR signaling cascade 
without the need for direct interaction might be that one or more proteins could be 
involved to convey the effects. So-called scaffolding proteins are key-components in the 
assembly of signaling platforms and multiprotein clusters. 
One possible candidate for this is the Connector Enhancer of KSR1 (CNK1). 
Mass spectrometry studies have identified cytohesins as major binding partners of 
CNK1 by interaction of the proteins´ coiled-coil-domains. In insulin signaling, CNK1 
seems to facilitate the membrane recruitment of cytohesins and Arf1, resulting in 
increased PI3K/AKT signaling and the formation of PIP2 - enriched microdomains in 
the membrane environment 136. In Drosophila, the cytohesin homologue Steppke has 
been shown to be involved in insulin signaling as well as in MAPK activation 
downstream of the EGFR. The interaction of Steppke with dCNK, the only CNK 
homologue in Drosophila, is necessary for its function in the EGFR signaling 194. 
Therefore, involvement of ARNO and the EGFR cascade in the CNK1 scaffolding 
complex could be an interesting subject for further studies. 
Other scaffolding complexes cytohesins have been reported to be part of include GRP1–
associated scaffolding protein (GRASP) 195. The general receptor for 3–
phosphoinositides (GRP1) is a GEF for Arf6 and activated downstream of the insulin 
receptor through phosphorylation by Akt, linking the complex to receptor tyrosine 
kinase signaling 196. In C.elegans, GRP1 and Arf1 form functional complexes with 
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PIP5K regulating PIP2 production in the plasma membrane as part of the Insulin/IGF 
pathway 197. 
So, even the lack of definite evidence for direct interaction does not exclude the 
existence of a biologically relevant relationship between ARNO and the EGFR. 
 
 
5.5 Summary 
The ARNO domains contribute to plasma membrane binding in a cooperative manner: 
The interaction between the PH - domain and PIPs is crucial and can be regulated via 
the concentration of Ca2+ ions. However, this interaction is not sufficient for anchoring 
the protein in the membrane. Additional binding of the polybasic region to anionic 
phospholipids is required to secure the membrane association. Dimerization of ARNO 
through its coiled–coil–domain increases the ability to bind to the membrane. Absence 
of the Sec7–domain impairs binding to a small extent. However, functional GEF 
activity is not required. 
In the plasma membrane, ARNO and EGFR clusters overlap partially. 
The relative standard deviation of the EGFR clusters and their staining intensity is 
altered after incubation with ARNO suggesting an influence on cluster density or the C 
– terminal tail´s conformation. 
In a cellular context, overexpression of ARNO results in a trend towards increased 
EGFR phosphorylation or activation, respectively. No effect on the EGFR´s nuclear 
translocation could be detected. 
Overall, the data in this study reveal new insights in ARNO–membrane association and 
suggest a functional relationship with EGFR clusters, probably as parts of the same 
complex signaling platforms. 
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7 Appendix 
 
7.1 Protein Sequences 
 
7.1.1 ARNO-GFP 
MGSHHHHHHENLYFQGSMEDGVYEPPDLTPEERMELENIRRRKQELLVEIQRL
REELSEAMSEVEGLEANEGSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENEL
LQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQ
ALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIML
NTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDD
GNDLTHTFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPR
GIIPLENLSIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRI
SAPTQEEKDEWIKSIQAAVSVDPFYEMLAARKKRISVKKKQEQPMVSKGEELFT
GVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTT
LTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFE
GDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRH
NIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLE
FVTAAGITLGMDELYK* 
 
 
7.1.2 PH-GFP 
MGSHHHHHHENLYFQGSGSDREGWLLKLGGGRVKTWKRRWFILTDNCLYYF
EYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVV
EGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPFYEMVSKGEELFTGVVPILVEL
DGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCF
SRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIE
LKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQL
ADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITL
GMDELYK* 
 
 
7.1.3 Sec7-PH-GFP 
MGSHHHHHHENLYFQGSRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEE
IARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFL
WSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHN
PNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTH
TFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENL
SIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEE
KDEWIKSIQAAVSVDPFYEMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGE
GDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSA
MPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKL
EYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVL
LPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK* 
 
 
7.1.4 ∆CC-GFP 
MGSHHHHHHENLYFQGSRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEE
IARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFL
WSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHN
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PNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTH
TFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENL
SIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEE
KDEWIKSIQAAVSVDPFYEMLAARKKRISVKKKQEQPMVSKGEELFTGVVPILV
ELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQ
CFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNR
IELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSV
QLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGI
TLGMDELYK* 
 
 
7.1.5 ∆PBR-GFP 
MGSHHHHHHENLYFQGSMEDGVYEPPDLTPEERMELENIRRRKQELLVEIQRL
REELSEAMSEVEGLEANEGSKTLQRNRKMAMGRKKFNMDPKKGIQFLVENEL
LQNTPEEIARFLYKGEGLNKTAIGDYLGEREELNLAVLHAFVDLHEFTDLNLVQ
ALRQFLWSFRLPGEAQKIDRMMEAFAQRYCLCNPGVFQSTDTCYVLSFAVIML
NTSLHNPNVRDKPGLERFVAMNRGINEGGDLPEELLRNLYDSIRNEPFKIPEDD
GNDLTHTFFNPDREGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPR
GIIPLENLSIREVDDPRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRI
SAPTQEEKDEWIKSIQAAVSVDPFYEMVSKGEELFTGVVPILVELDGDVNGHKF
SVSGEGEGDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQ
HDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDG
NILGHKLEYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTP
IGDGPVLLPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK* 
 
 
7.1.6 Gn4Lz-Sec7-PH-GFP 
MGSHHHHHHENLYFQGSRVKQLEDKVEELLSKNAHLENEVARLKKLRNRKM
AMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGER
EELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQRY
CLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEGG
DLPEELLRNLYDSIRNEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGGRVKTWK
RRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYIPNNKGQL
IKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPFYEMVSKG
EELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKFICTTGKLPVPWP
TLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYIMADKQKNGIKVN
FKIRHNIEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQSKLSKDPNEKRDHM
VLLEFVTAAGITLGMDELYK* 
 
7.1.7 GST-PH-PBR-GFP 
MGSHHHHHHENLYFQGSMSPILGYWKIKGLVQPTRLLLEYLEEKYEEHLYERD
EGDKWRNKKFELGLEFPNLPYYIDGDVKLTQSMAIIRYIADKHNMLGGCPKER
AEISMLEGAVLDIRYGVSRIAYSKDFETLKVDFLSKLPEMLKMFEDRLCHKTYL
NGDHVTHPDFMLYDALDVVLYMDPMCLDAFPKLVCFKKRIEAIPQIDKYLKSS
KYIAWPLQGWQATFGGGDHPPKSDEDDGNDLTHTFFNPDREGWLLKLGGGRV
KTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYIPN
NKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPFYE
MLAARKKRISVKKKQEQPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGE
GDATYGKLTLKFICTTGKLPVPWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSA
MPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKL
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EYNYNSHNVYIMADKQKNGIKVNFKIRHNIEDGSVQLADHYQQNTPIGDGPVL
LPDNHYLSTQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYK* 
 
7.1.8 SBP-PH 
MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPSGENLYFQGSEFDR
EGWLLKLGGGRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDD
PRKPNCFELYIPNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKS
IQAAVSVDPFYEMLAA 
 
 
7.1.9 SBP-ARNO 
MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPSGENLYFQGSMEDG
VYEPPDLTPEERMELENIRRRKQELLVEIQRLREELSEAMSEVEGLEANEGSKTL
QRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIG
DYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMME
AFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNR
GINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGG
RVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYI
PNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPF
YEMLAARKKRISVKKKQEQP 
 
 
7.1.10 SBP-E156K 
MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPSGENLYFQGSMEDG
VYEPPDLTPEERMELENIRRRKQELLVEIQRLREELSEAMSEVEGLEANEGSKTL
QRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIG
DYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGKAQKIDRMM
EAFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMN
RGINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTHTFFNPDREGWLLKLGG
GRVKTWKRRWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELY
IPNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPF
YEMLAARKKRISVKKKQEQP 
 
 
7.1.11 SBP-R280C 
MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPSGENLYFQGSMEDG
VYEPPDLTPEERMELENIRRRKQELLVEIQRLREELSEAMSEVEGLEANEGSKTL
QRNRKMAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIG
DYLGEREELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMME
AFAQRYCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNR
GINEGGDLPEELLRNLYDSIRNEPFKIPEDDGNDLTHTFFNPDREGWLLKLGGG
RVKTWKRCWFILTDNCLYYFEYTTDKEPRGIIPLENLSIREVDDPRKPNCFELYI
PNNKGQLIKACKTEADGRVVEGNHMVYRISAPTQEEKDEWIKSIQAAVSVDPF
YEMLAARKKRISVKKKQEQP 
 
 
7.1.12 SBP-Sec7 
MDEKTTGWRGGHVVEGLAGELEQLRARLEHHPQGQREPSGENLYFQGSRNRK
MAMGRKKFNMDPKKGIQFLVENELLQNTPEEIARFLYKGEGLNKTAIGDYLGE
REELNLAVLHAFVDLHEFTDLNLVQALRQFLWSFRLPGEAQKIDRMMEAFAQR
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YCLCNPGVFQSTDTCYVLSFAVIMLNTSLHNPNVRDKPGLERFVAMNRGINEG
GDLPEELLRNLYDSIRNEPFKIPED 
 
 
7.2 Protein purification 
 
7.2.1 SBP-tagged proteins 
 
 
SI Figure 1: Coomassie gels of the purification process of the SBP-tagged proteins. 1: 
Before induction, 2: After induction, 3: Supernatant after lysis, 4: Supernatant after 
incubation with affinity beads, 5: Eluate, 6: Final sample, 7: Product after Gelfiltration. 
Expected MW: SBP-ARNO: 52 kDa, SBP-Sec7: 27 kDa, SBP-E156K: 52 kDa, SBP-
R280C: 52 kDa, SBP-PH: 20,3 kDa. 
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SI Figure 2: Gel filtration curves of SBP-tagged proteins. 
 
 
7.2.2 GFP-tagged proteins 
 
 
SI Figure 3: Coomassie gels for control of the purification of the GFP-tagged protein 
constructs. : 0: After induction, 1: Supernatant after lysis, 2: Supernatant after 
incubation with affinity beads, 3: Eluate, 4: After TEV digest, 5: Flowthrough of 
rebinding column, 6: Wash fraction, 7: Eluate, 8: Final product after gelfiltration 
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.Expected MW: ARNO-GFP: 75.5 kDa, PH-GFP: 43.4 kDa, Sec7-PH-GFP: 66.4 kDa, 
∆PBR-GFP: 73.4 kDa, Lz-Sec7-PH-GFP: 69.8 kDa 
 
 
 
SI Figure 4: Gel filtration curves of GFP-tagged proteins. 
 
 
7.3 Plasmid sequences 
 
7.3.1 pGFP-PK 
GCGGCCGCGATCTCTCGGCTGGACGAGCTGTACAGTACTCAGATCTCGAGC
TCAAGCTTCGAATTAATTCCCACGCTGCCATGGCAGACACCTTTCTGGAGCA
CATGTGCCGCCTGGACATCGACTCCGAGCCAACCATTGCCAGAAACACCGG
CATCATCTGCACCATCGGCCCAGCCTCCCGCTCTGTGGACAAGCTGAAGGA
AATGATTAAATCTGGAATGAATGTTGCCCGCCTCAACTTCTCGCACGGCACC
CACGAGTATCATGAGGGCACAATTAAGAACGTGCGAGAGGCCACAGAGAG
CTTTGCCTCTGACCCGATCACCTACAGACCTGTGGCTATTGCACTGGACACC
AAGGGACCTGAAATCCGAACTGGACTCATCAAGGGAAGTGGCACAGCAGA
GGTGGAGCTCAAGAAGGGCGCAGCTCTCAAAGTGACGCTGGACAATGCCTT
CATGGAGAACTGCGATGAGAATGTGCTGTGGGTGGACTACAAGAACCTCAT
CAAAGTTATAGATGTGGGCAGCAAAATCTATGTGGATGACGGTCTCATTTCC
TTGCTGGTTAAGGAGAAAGGCAAGGACTTTGTCATGACTGAGGTTGAGAAC
GGTGGCATGCTTGGTAGTAAGAAGGGAGTGAACCTCCCAGGTGCTGCGGTC
GACCTGCCTGCAGTCTCAGAGAAGGACATTCAGGACCTGAAATTTGGCGTG
GAGCAGAATGTGGACATGGTGTTCGCTTCCTTCATCCGCAAAGCTGCTGATG
TCCATGCTGTCAGGAAGGTGCTAGGGGAAAAGGGAAAGCACATCAAGATTA
TCAGCAAGATTGAGAATCACGAGGGTGTGCGCAGGTTTGATGAGATCATGG
AGGCCAGCGATGGCATTATGGTGGCCCGTGGTGACCTGGGTATTGAGATCC
CTGCTGAAAAAGTCTTCCTCGCACAGAAGATGATGATTGGGCGCTGCAACA
GGGCTGGCAAACCCATCATTTGTGCCACTCAGATGTTGGAAAGCATGATCA
AGAAACCTCGCCCGACCCGCGCTGAGGGCAGTGATGTTGCCAATGCAGTTC
TGGATGGAGCAGACTGCATCATGCTGTCTGGGGAGACCGCCAAGGGAGACT
ACCCACTGGAGGCTGTGCGCATGCAGCACGCTATTGCTCGTGAGGCTGAGG
APPENDIX 
 
CCGCAATGTTCCATCGTCAGCAGTTTGAAGAAATCTTACGCCACAGTGTACA
CCACAGGGAGCCTGCTGATGCCATGGCAGCAGGCGCGGTGGAGGCCTCCTT
TAAGTGCTTAGCAGCAGCTCTGATAGTTATGACCGAGTCTGGCAGGTCTGCA
CGCCTGGTGTCCCGGTACCGCGGGCCCGGGATCCACCGGATCTAGATAAAC
TGATCATATCAGCCTACCACTC 
 
7.3.2 pGFP-EGFRJM-PK 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTC
GAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACC
GGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCA
AGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGG
ACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACC
CTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAAC
ATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATC
ATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCAC
AACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACC
CCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACC
CAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTG
CTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTAC
AAGTACTCAGATCTCGAGCTCAAGCTTCGAATTAATTCCCACGCTGCCATGG
CAGACACCTTTCTGGAGCACATGTGCCGCCTGGACATCGACTCCGAGCCAA
CCATTGCCAGAAACACCGGCATCATCTGCACCATCGGCCCAGCCTCCCGCTC
TGTGGACAAGCTGAAGGAAATGATTAAATCTGGAATGAATGTTGCCCGCCT
CAACTTCTCGCACGGCACCCACGAGTATCATGAGGGCACAATTAAGAACGT
GCGAGAGGCCACAGAGAGCTTTGCCTCTGACCCGATCACCTACAGACCTGT
GGCTATTGCACTGGACACCAAGGGACCTGAAATCCGAACTGGACTCATCAA
GGGAAGTGGCACAGCAGAGGTGGAGCTCAAGAAGGGCGCAGCTCTCAAAG
TGACGCTGGACAATGCCTTCATGGAGAACTGCGATGAGAATGTGCTGTGGG
TGGACTACAAGAACCTCATCAAAGTTATAGATGTGGGCAGCAAAATCTATG
TGGATGACGGTCTCATTTCCTTGCTGGTTAAGGAGAAAGGCAAGGACTTTGT
CATGACTGAGGTTGAGAACGGTGGCATGCTTGGTAGTAAGAAGGGAGTGAA
CCTCCCAGGTGCTGCGGTCGACCTGCCTGCAGTCTCAGAGAAGGACATTCA
GGACCTGAAATTTGGCGTGGAGCAGAATGTGGACATGGTGTTCGCTTCCTTC
ATCCGCAAAGCTGCTGATGTCCATGCTGTCAGGAAGGTGCTAGGGGAAAAG
GGAAAGCACATCAAGATTATCAGCAAGATTGAGAATCACGAGGGTGTGCGC
AGGTTTGATGAGATCATGGAGGCCAGCGATGGCATTATGGTGGCCCGTGGT
GACCTGGGTATTGAGATCCCTGCTGAAAAAGTCTTCCTCGCACAGAAGATG
ATGATTGGGCGCTGCAACAGGGCTGGCAAACCCATCATTTGTGCCACTCAG
ATGTTGGAAAGCATGATCAAGAAACCTCGCCCGACCCGCGCTGAGGGCAGT
GATGTTGCCAATGCAGTTCTGGATGGAGCAGACTGCATCATGCTGTCTGGG
GAGACCGCCAAGGGAGACTACCCACTGGAGGCTGTGCGCATGCAGCACGCT
ATTGCTCGTGAGGCTGAGGCCGCAATGTTCCATCGTCAGCAGTTTGAAGAA
ATCTTACGCCACAGTGTACACCACAGGGAGCCTGCTGATGCCATGGCAGCA
GGCGCGGTGGAGGCCTCCTTTAAGTGCTTAGCAGCAGCTCTGATAGTTATGA
CCGAGTCTGGCAGGTCTGCACGCCTGGTGTCCCGGTACCGAAGACGCCACA
TCGTTCGGAAGCGCACGCTGCGGAGGCTGCTGCAGGAGAGGGAGCTTGTGG
AGCCTCTTACACCCAGTGGAGAAGCTCCCAACCAAGCTCTCTTGAGGATC 
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7.3.3 pCMVTag2-ARNO 
ATGGAGGATGGCGTCTATGAACCCCCAGACCTGACTCCGGAGGAGCGGATG
GAGCTGGAGAACATCCGGCGGCGGAAGCAGGAGCTGCTGGTGGAGATTCA
GCGCCTGCGGGAGGAGCTCAGTGAAGCCATGAGCGAGGTGGAGGGGCTGG
AGGCCAATGAGGGCAGTAAGACCTTGCAACGGAACCGGAAGATGGCAATG
GGCAGGAAGAAGTTCAACATGGACCCCAAGAAGGGGATCCAGTTCTTGGTG
GAGAATGAACTGCTGCAGAACACACCCGAGGAGATCGCCCGCTTCCTGTAC
AAGGGCGAGGGGCTGAACAAGACAGCCATCGGGGACTACCTGGGGGAGAG
GGAAGAACTGAACCTGGCAGTGCTCCATGCTTTTGTGGATCTGCATGAGTTC
ACCGACCTCAATCTGGTGCAGGCCCTCAGGCAGTTTCTATGGAGCTTTCGCC
TACCCGGAGAGGCCCAGAAAATTGACCGGATGATGGAGGCCTTCGCCCAGC
GATACTGCCTGTGCAACCCTGGGGTTTTCCAGTCCACAGACACGTGCTATGT
GCTGTCCTTCGCCGTCATCATGCTCAACACCAGTCTCCACAATCCCAATGTC
CGGGACAAGCCGGGCCTGGAGCGCTTTGTGGCCATGAACCGGGGCATCAAC
GAGGGCGGGGACCTGCCTGAGGAGCTGCTCAGGAACCTGTACGACAGCATC
CGAAATGAGCCCTTCAAGATTCCTGAGGATGACGGGAATGACCTGACCCAC
ACCTTCTTCAACCCGGACCGGGAGGGCTGGCTCCTGAAGCTGGGAGGGGGC
CGGGTGAAGACGTGGAAGCGGCGCTGGTTTATCCTCACAGACAACTGCCTC
TACTACTTTGAGTACACCACGGACAAGGAGCCCCGAGGAATCATCCCCCTG
GAGAATCTGAGCATCCGAGAGGTGGACGACCCCCGGAAACCGAACTGCTTT
GAACTTTACATCCCCAACAACAAGGGGCAGCTCATCAAAGCCTGCAAAACT
GAGGCGGACGGCCGAGTGGTGGAGGGAAACCACATGGTGTACCGGATCTC
GGCCCCCACGCAGGAGGAGAAGGACGAGTGGATCAAGTCCATCCAGGCGG
CTGTGAGTGTGGACCCCTTCTATGAGATGCTGGCAGCGAGAAAGAAGCGGA
TTTCAGTCAAGAAGAAGCAGGAGCAGCCC 
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7.4 Complete original westernblots 
 
 
SI Figure 5: Full Westernblot corresponding to Figure 23. The part stained for the 
HA-tag is not shown in the Figure. 
 
 
 
SI Figure 6: Full Westernblot corresponding to Figure 25. Lanes 1-6 are shown in the 
Figure, on the right part of the blot, a repetition of the experiment is shown. 
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SI Figure 7: Full Westernblots corresponding to Figure 26. Lanes 1-5 are shown in 
the Figure, the neighbouring lanes are a repetition of the experiment. The Lamin and 
GAPDH stainings are not shown in the Figure. 
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SI Figure 8: Full Westernblots corresponding to Figure 30. Lanes 1-3 are shown in 
the Figure; the others are repetitions of the experiment. 
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7.5 Characterization of Alexa594-PD168393 
 
 
SI Figure 9: LCMS analysis of Alexa594-PD168393. Compound and LCMS data 
kindly provided by Dr. Jeff Hannam 
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9 Zusammenfassung 
Die Kompartimentalisierung von eukaryotischen Zellen durch Lipidmembranen dient 
der Trennung von biologischen Prozessen und Signalwegen. Der kontrollierte Transport 
von Proteinen zwischen Zellkompartimenten sowie die Rekrutierung der Proteine an die 
jeweiligen Membranen ist entscheidend für die einwandfreie Funktion der Zelle. 
Verschiedene Möglichkeiten der Interaktion zwischen Proteinen und Membranen sind 
Gegenstand der Forschung. Beispielsweise interagieren Phosphoinositide spezifisch mit 
bestimmten Proteindomänen, wobei die anionischen Lipide eine elektrostatische 
Anziehung auf positiv geladene Proteindomänen ausüben. 
Hauptfokus dieser Arbeit ist der Guanine-Nukleotid-Austauschfaktor ARNO, ein aus 
mehreren Domänen bestehendes Protein, welches die kleine GTPase Arf6 aktiviert und 
somit ein Teil der Vesikeltransport-Maschinerie der Zelle ist. 
In seiner autoinhibierten Form liegt ARNO zytoplasmatisch vor, seine Rekrutierung zur 
Plasmamembran ist Grundvoraussetzung für die Aktivierung von Arf. 
In diesem Zusammenhang haben sich vorangegangene Forschungsarbeiten auf die 
Interaktion zwischen der PH-Domäne und der PBR-Domäne mit artifiziellen 
Membransystemen konzentriert. Um die daraus gewonnenen Erkenntnisse in einem 
System zu erweitern, welches der enormen Komplexität der zellulären Plasmamembran 
Rechnung zu trägt, wurden in dieser Studie native Plasmamembranen für 
Bindungsstudien verwendet. Systematisch wurde die Rolle der verschiedenen ARNO-
Domänen in der Bindung an zellfreie Plasmamembranen untersucht. 
Es hat sich gezeigt, dass verschiedene ARNO-Domänen zur Interaktion mit der 
Membran auf kooperative Art und Weise beitragen. Während die PH-Domäne für die 
Assoziation des Proteins an die Membran absolut notwendig ist, ist sie jedoch nicht 
ausreichend um das Protein in der Membran zu verankern. Weiterhin wurde beobachtet, 
dass die Interaktion zwischen der PH-Domäne und den Phosphoinositiden durch den 
second messenger Ca2+ stark beeinflusst wird. Die Bindungsstudien dieser Arbeit 
zeigten weiterhin, dass die PBR-Domäne, die Sec7-Domäne sowie die Coiled-coil-
Domäne zur Bindung an die Plasmamembran beitragen. Darüber hinaus verstärkt die 
Dimerisierung von ARNO die Bindung an die Plasmamembran, vermutlich aufgrund 
der Vergrößerung der lokalen Avidität. 
Die mikroskopischen Analysen haben gezeigt, dass membrangebundenes ARNO in 
Clustern organisiert ist, die zum Teil eng mit EGFR Clustern assoziiert sind.  
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Die Überexpression von ARNO in HeLa Zellen führt zu einer Tendenz zur vermehrten 
Aktivierung des EGFR nach Stimulation mit EGF. 
Beides deutet auf eine mögliche funktionelle Verbindung des EGFR-trafficking bzw. 
dessen Phosphorylierung und ARNO hin, die durch den second messenger Kalzium 
reguliert werden könnte. 
Aktivierter EGFR kann mittels retrogradem endosomalen Transport in den Zellkern 
befördert werden. In Bezug auf diesen speziellen Transportweg wurde in dieser Studie 
kein Einfluss einer Überexpression oder Inhibition von ARNO gefund
